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A B S T R A C T
Background
Current guidelines recommend screening of people with oesophageal varices via oesophago-gastro-duodenoscopy at the time of diagnosis
of hepatic cirrhosis. This requires that people repeatedly undergo unpleasant invasive procedures with their attendant risks, although
half of these people have no identifiable oesophageal varices 10 years after the initial diagnosis of cirrhosis. Platelet count, spleen length,
and platelet count-to-spleen length ratio are non-invasive tests proposed as triage tests for the diagnosis of oesophageal varices.
Objectives
Primary objectives
To determine the diagnostic accuracy of platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of
oesophageal varices of any size in paediatric or adult patients with chronic liver disease or portal vein thrombosis, irrespective of aetiology.
To investigate the accuracy of these non-invasive tests as triage or replacement of oesophago-gastro-duodenoscopy.
Secondary objectives
To compare the diagnostic accuracy of these same tests for the diagnosis of high-risk oesophageal varices in paediatric or adult patients
with chronic liver disease or portal vein thrombosis, irrespective of aetiology.
We aimed to perform pair-wise comparisons between the three index tests, while considering predefined cut-off values.
We investigated sources of heterogeneity.
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Search methods
The Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Hepato-Biliary Group Diagnostic Test Accuracy Studies
Register, the Cochrane Library, MEDLINE (OvidSP), Embase (OvidSP), and Science Citation Index - Expanded (Web of Science)
(14 June 2016). We applied no language or document-type restrictions.
Selection criteria
Studies evaluating the diagnostic accuracy of platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis
of oesophageal varices via oesophago-gastro-duodenoscopy as the reference standard in children or adults of any age with chronic liver
disease or portal vein thrombosis, who did not have variceal bleeding.
Data collection and analysis
Standard Cochrane methods as outlined in the Cochrane Handbook for Diagnostic Test of Accuracy Reviews.
Main results
We included 71 studies, 67 of which enrolled only adults and four only children. All included studies were cross-sectional and were
undertaken at a tertiary care centre. Eight studies reported study results in abstracts or letters. We considered all but one of the included
studies to be at high risk of bias. We had major concerns about defining the cut-off value for the three index tests; most included studies
derived the best cut-off values a posteriori, thus overestimating accuracy; 16 studies were designed to validate the 909 (n/mm3)/mm
cut-off value for platelet count-to-spleen length ratio. Enrolment of participants was not consecutive in six studies and was unclear in
31 studies. Thirty-four studies assessed enrolment consecutively. Eleven studies excluded some included participants from the analyses,
and in only one study, the time interval between index tests and the reference standard was longer than three months.
Diagnosis of varices of any size. Platelet count showed sensitivity of 0.71 (95% confidence interval (CI) 0.63 to 0.77) and specificity
of 0.80 (95% CI 0.69 to 0.88) (cut-off value of around 150,000/mm3 from 140,000 to 150,000/mm3 ; 10 studies, 2054 participants).
When examining potential sources of heterogeneity, we found that of all predefined factors, only aetiology had a role: studies including
participants with chronic hepatitis C reported different results when comparedwith studies including participants withmixed aetiologies
(P = 0.036). Spleen length showed sensitivity of 0.85 (95% CI 0.75 to 0.91) and specificity of 0.54 (95% CI 0.46 to 0.62) (cut-
off values of around 110 mm, from 110 to 112.5 mm; 13 studies, 1489 participants). Summary estimates for detection of varices of
any size showed sensitivity of 0.93 (95% CI 0.83 to 0.97) and specificity of 0.84 (95% CI 0.75 to 0.91) in 17 studies, and 2637
participants had a cut-off value for platelet count-to-spleen length ratio of 909 (n/mm3)/mm.We found no effect of predefined sources
of heterogeneity. An overall indirect comparison of the HSROCs of the three index tests showed that platelet count-to-spleen length
ratio was the most accurate index test when compared with platelet count (P < 0.001) and spleen length (P < 0.001).
Diagnosis of varices at high risk of bleeding. Platelet count showed sensitivity of 0.80 (95% CI 0.73 to 0.85) and specificity of 0.68
(95% CI 0.57 to 0.77) (cut-off value of around 150,000/mm3 from 140,000 to 160,000/mm3 ; seven studies, 1671 participants). For
spleen length, we obtained only a summary ROC curve as we found no common cut-off between studies (six studies, 883 participants).
Platelet count-to-spleen length ratio showed sensitivity of 0.85 (95% CI 0.72 to 0.93) and specificity of 0.66 (95% CI 0.52 to 0.77)
(cut-off value of around 909 (n/mm3)/mm; from 897 to 921 (n/mm3)/mm; seven studies, 642 participants). An overall indirect
comparison of the HSROCs of the three index tests showed that platelet count-to-spleen length ratio was the most accurate index test
when compared with platelet count (P = 0.003) and spleen length (P < 0.001).
DIagnosis of varices of any size in children. We found four studies including 277 children with different liver diseases and or portal
vein thrombosis. Platelet count showed sensitivity of 0.71 (95% CI 0.60 to 0.80) and specificity of 0.83 (95% CI 0.70 to 0.91) (cut-
off value of around 115,000/mm3 ; four studies, 277 participants). Platelet count-to-spleen length z-score ratio showed sensitivity of
0.74 (95% CI 0.65 to 0.81) and specificity of 0.64 (95% CI 0.36 to 0.84) (cut-off value of 25; two studies, 197 participants).
Authors’ conclusions
Platelet count-to-spleen length ratio could be used to stratify the risk of oesophageal varices. This test can be used as a triage test before
endoscopy, thus ruling out adults without varices. In the case of a ratio > 909 (n/mm3)/mm, the presence of oesophageal varices of
any size can be excluded and only 7% of adults with varices of any size would be missed, allowing investigators to spare the number
of oesophago-gastro-duodenoscopy examinations. This test is not accurate enough for identification of oesophageal varices at high risk
of bleeding that require primary prophylaxis. Future studies should assess the diagnostic accuracy of this test in specific subgroups of
patients, as well as its ability to predict variceal bleeding. New non-invasive tests should be examined.
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P L A I N L A N G U A G E S U M M A R Y
Platelet count, spleen length, and platelet-to-spleen length ratio for the diagnosis of oesophageal varices in people with liver
disease
Background
Hepatic cirrhosis is a severe disease with scars and nodules on the liver tissue. As a result, the normal function of the liver is impaired.
Whatever the cause of cirrhosis, changes in the structure of and blood flow within the liver increase pressure in the portal vein (called
portal vein hypertension), which is the vein that drains blood from the bowels to the liver. Portal hypertension induces dilatation
(extension) of veins within the wall of the oesophagus (food pipe or gullet), which often rupture (break) with severe bleeding. Thus,
when liver cirrhosis is diagnosed, an oesophago-gastro-duodenoscopy (OGD) is recommended to detect the presence of oesophageal
varices (areas of abnormal dilatation of veins). During OGD, a small camera at the end of a tube is inserted down the oesophagus
from the mouth and pictures are relayed back to a screen. Large varices or red signs on even small varices show high risks of rupture
and bleeding. If high-risk varices are found, treatment with beta-blockers is effective in reducing the risk of bleeding. Three simple
non-invasive tests could be used to identify people with liver diease at high risk of having oesophageal varices: platelet count - a simple
laboratory test on a blood sample by which the number of platelets (a blood element ensuring coagulation) is measured; length (maximal
diameter) of the spleen measured during ultrasound examination of the abdomen; and ratio of platelet count to spleen length.
Study characteristics
We searched scientific databases for clinical studies comparing platelet count, spleen length, or platelet count-to-spleen length ratio
versus oesophago-gastro-duodenoscopy in detecting the presence of varices in children or adults with chronic liver disease or portal
vein thrombosis (narrowing of the portal vein). The evidence is current to June 2016.
Key results
We found 25 studies with 5096 participants assessing the use of platelet count to diagnose the presence of varices and grade the
risk of bleeding, and comparing platelet count versus oesophago-gastro-duodenoscopy in adults with cirrhosis: 13 studies with 1489
participants assessed the diagnostic ability of spleen length, and 38 studies with 5235 participants assessed the diagnostic ability of
platelet count-to-spleen length ratio. Platelet count-to-spleen length ratio was the most accurate and could be used to identify people
with liver disease who were at high risk of having oesophageal varices. Particularly, in people with hepatic cirrhosis among whom 580
out of 1000 people are expected to have oesophageal varices, only 41 (7% of 580) people will be missed as having varices and will have
no appropriate preventive treatment or follow-up. Thus, if platelet count-to-spleen length ratio is lower than 909 (n/mm3)/mm (the
most used threshold), the presence of oesophageal varices can be excluded. Thus, it is possible to reduce the number of endoscopic
examinations needed to find a person with oesophageal varices. On the contrary, this ratio is not accurate enough to replace endoscopy
for identification of high risk of bleeding oesophageal varices.
Quality of the evidence
All but one study had problems of risk of bias involving mainly the definition of positive or negative index tests (platelet count, spleen
length, and their ratio), which should be defined before and not after data analyses, and blinding of test results to the endoscopists who
performed oesophago-gastro-duodenoscopy. Hence, these problems could impair the accuracy estimates of the three tests.
B A C K G R O U N D
Oesophageal varices in portal hypertension
Portal hypertension commonly accompanies advanced liver dis-
ease and often gives rise to life-threatening complications, includ-
ing haemorrhage from oesophageal and gastrointestinal varices.
Prevalence of cirrhosis in high-income countries ranges from0.4%
to 1.1% of the population (Bellentani 1994; Quinn 1997); up to
two thirds of people with cirrhosis will develop gastro-oesophageal
varices (Pagliaro 1992; D’Amico 1999; Jensen 2002). The inci-
dence of oesophageal varices among people with compensated cir-
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rhosis is around 5% per year (Merli 2003; Groszmann 2005), and
the cumulative incidence among people with well-defined com-
pensated cirrhosis seems lower: 44% at 10 years and 53% at 20
years (D’Amico 2014). Gastro-oesophageal varices are an exten-
sion of oesophageal varices; isolated gastric varices in the absence of
oesophageal varices are rare and usually are associated with splenic
vein thrombosis (Garcia-Tsao 2007). As varices grow larger, they
become more likely to rupture and bleed (Lebrec 1980; NIEC
1988). Haemorrhage from ruptured oesophageal varices is one of
the most common causes of gastrointestinal bleeding and is the
most common cause of death among individuals with cirrhosis
(D’Amico 2006 a; Garcia-Tsao 2007). Studies conducted by the
Northern Italian Endoscopic Club have shown that bleeding over
two years occurs at a frequency of up to 30% from large varices
compared with 5% to 18% from small varices (NIEC 1988; Zoli
1996; D’Amico 1999). Variceal bleeding is a medical emergency
that, in spite of recent progress, is associated withmortality of 10%
to 20% at six weeks. Up to 30% of initial bleeding episodes are
fatal, and bleeding recurs among 70% of survivors (Graham 1981;
NIEC 1988; Sharara 2001; D’Amico 2003; Bambha 2008). How-
ever, primary prophylaxiswith non-selective beta blockers or endo-
scopic variceal banding lowers the incidence of first variceal haem-
orrhage, especially from medium to large varices (Garcia-Tsao
2008; de Franchis 2015). Detection of oesophageal varices allows
one to define the bleeding risk and to identify progression to de-
compensated cirrhosis associated with further complications and a
poor prognosis requiring more intense follow-up (D’Amico 2006
b; D’Amico 2014).
Current North American European and Asian Pacific guidelines
for detection and management of oesophageal varices recom-
mend performance of oesophago-gastro-duodenoscopy to screen
for oesophageal varices at the time hepatic cirrhosis is diag-
nosed (Garcia-Tsao 2007; Sarin 2008; ASGEStandards of Practice
Committee 2012). However, the point prevalence of oesophageal
varices requiring prophylaxis is only about 15% to 25%, and most
people undergoing screening oesophago-gastro-duodenoscopy do
not have varices or have varices that do not require treatment.
Moreover, oesophago-gastro-duodenoscopy is an invasive proce-
dure that often requires sedation and may be associated with seri-
ous, even rare, complications and with frequent unexpected hos-
pital admissions (Silvis 1976; Wolfsen 2004; Geraci 2009; Leffler
2010). Therefore, a cost-effective triage pathway must be devel-
oped to select people whowill benefit fromoesophago-gastro-duo-
denoscopy screening. A recent consensus conference (de Franchis
2015) identified individuals with chronic liver disease who could
safely avoid screening endoscopy because their risk of oesophageal
varices was very low when liver stiffness was measured by transient
elastography < 20 kPa and a platelet count > 150,000 per mm3.
However no systematic review supports this recommendation (de
Franchis 2015).
A non-invasive test can play the role of a triage test if it can serve to
accurately rule out the presence of varices withoutmissing effective
treatments, and hence to reduce the use of endoscopy, reserving its
use for people with positive results. A non-invasive test may even
be more accurate than the reference standard, that is, oesophago-
gastro-duodenoscopy, which is limited by interobserver reliability,
which is poor even for the definition of the presence of varices
and for assessment of their size and volume (Winkfield 2003).
In such a case, the non-invasive test could replace the reference
standard. However, for a non-invasive test to replace oesophago-
gastro-duodenoscopy as the preferred diagnostic test for varices, it
should accurately demonstrate the presence of varices while pro-
viding qualitative information that currently can be gained only
from endoscopy. It is important to note that the non-invasive test
should be able to predict the risk of variceal bleeding with as much
or greater accuracy than oesophago-gastro-duodenoscopy
Many non-invasive tests have been proposed for the diagnosis of
oesophageal varices. This systematic review is one of five that have
examined the diagnostic utility of these tests (Gana 2010a; Gana
2010b; Gana 2010c; Colli 2014b).
Target condition being diagnosed
Oesophageal varices
Oesophageal varices of any size were diagnosed. Oesophageal
varices are dilated blood vessels within the wall of the oesopha-
gus that develop when resistance to blood flow through the liver
is increased as the result of cirrhosis or portal vein obstruction.
Large oesophageal varices are associated with greater risk of bleed-
ing than are smaller varices. Red marks (or red signs) on varices
diagnosed during oesophago-gastro-duodenoscopy have also been
associated with increased bleeding risk (JSPH 1980; NIEC 1988;
Garcia-Tsao 2007; Garcia-Tsao 2008). Medium varices were clas-
sified as large varices, as suggested by the American Association for
the Study of Liver Diseases, because recommendations for man-
agement of medium-sized varices are the same as for large varices
(Garcia-Tsao 2007).
Index test(s)
Platelet count, spleen length, and platelet count-to-
spleen length ratio
If non-invasive tests predict the presence of oesophageal varices
with sufficient accuracy, then oesophago-gastro-duodenoscopy
can be limited to patients identified to be at high risk of varices.
Certain blood tests and imaging modalities and calculations based
on their results have shown a promising correlation with oe-
sophageal varices. Of these, the most frequently studied non-inva-
sive tests are platelet count and ultrasound measurements of spleen
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length. Increased spleen length in patients with chronic liver dis-
ease is almost always caused by increased portal pressure (Pockros
2002; Liangpunsakul 2003). Thrombocytopenia may be the re-
sult of splenic pooling of platelets due to portal hypertension, im-
mune-mediated mechanisms, or reduced thrombopoietin synthe-
sis (Peck-Radosavljevic 2000;Giannini 2003a; Peck-Radosavljevic
2007). Integrating platelet count and spleen length in a ratio pro-
vides a measure of the degree of thrombocytopenia that may re-
sult from hypersplenism. This review aims to evaluate the diag-
nostic accuracy of platelet count, spleen length, or platelet count-
to-spleen length ratio in predicting the presence of oesophageal
varices.
Clinical pathway
At the time of diagnosis of hepatic cirrhosis of whatever aetiol-
ogy, an oesophago-gastro-duodenoscopy is recommended to de-
tect the presence of oesophageal varices and to define the risk of
their rupture and bleeding while providing an overall prognos-
tic assessment. In the case of high-risk varices (large varices or
presence of red marks), primary prophylaxis with a non-selective
beta-blocker or endoscopic banding ligation of varices has been
demonstrated to be effective andhence is recommended (D’Amico
1999; Imperiale 2001; Gluud 2007; Gluud 2012). If oesophago-
gastro-duodenoscopy reveals no varices, a repeated examination
is recommended in three years. If low-risk varices are seen (small
varices without red marks), then oesophago-gastro-duodenoscopy
should be repeated in two years. If small varices are associated with
red signs or with Child-Pugh score B-C (Pugh 1973), non-selec-
tive beta-blocker prophylaxis is recommended (Garcia-Tsao 2007;
Garcia-Tsao 2008; ASGE Standards of Practice Committee 2012;
de Franchis 2015).
Prior test(s)
The diagnosis of liver cirrhosis usually is based on clinical judge-
ment derived from history, laboratory testing, physical examina-
tion, imaging, liver histology, or a combination of these. No prior
test is recommended by the guidelines before screening with oe-
sophago-gastro-duodenoscopy of oesophageal varices when the di-
agnosis of cirrhosis is made.
Role of index test(s)
The possible role of platelet count, spleen length, and platelet
count-to-spleen length ratio involves screening people with a diag-
nosis of cirrhosis for the presence of varices, sparing oesophago-gas-
tro-duodenoscopy in people with negative results. Furthermore,
these non-invasive tests could even be so accurate in detecting
high-risk varices (large varices or presence of red marks) for which
primary prophylaxis is recommended that they could replace oe-
sophago-gastro-duodenoscopy.
Alternative test(s)
Some non-invasive tests other than platelet count, spleen length,
and platelet count-to-spleen length ratio have been proposed for
the diagnosis of oesophageal varices, such as serum markers for
liver fibrosis, transient elastography, or imaging with ultrasound
computed tomography,magnetic resonance, or capsule endoscopy
(Colli 2014b).
We will examine some of these tests in future planned reviews
(Gana 2010a; Gana 2010b; Gana 2010c).
Rationale
Effective prevention of the first variceal haemorrhage (primary
prophylaxis) in adults with medium or large varices can be
achieved via non-selective beta-blockers or endoscopic variceal lig-
ation (D’Amico 1999; Imperiale 2001; Gluud 2007). Therefore,
both North American (Grace 1998; Adams 2004; Garcia-Tsao
2007; Garcia-Tsao 2008) and European guidelines (Jalan 2000;
Garcia-Tsao 2008; EASL 2011; Tripathi 2015; NICE 2016) rec-
ommend endoscopy at the time of diagnosis of cirrhosis and at
intervals thereafter to identify at-risk patients who might bene-
fit from prophylactic treatment. These guidelines require that pa-
tients repeatedly undergo an unpleasant invasive procedure with
its attendant risks, although half have no identifiable oesophageal
varices 10 years after the initial diagnosis of cirrhosis. Oesophago-
gastro-duodenoscopy requires appropriate sedation and analgesia
(Cotton 2006) and is associated with an overall complication rate
of 0.13% and a mortality rate of 0.004% (Silvis 1976).
Two cost-effectiveness studies suggested avoidance of surveillance
oesophago-gastro-duodenoscopy and treatment with non-selec-
tive beta-blockers for all people with cirrhosis, irrespective of the
presence or size of varices (Saab 2003; Spiegel 2003). A third
cost-effectiveness analysis suggested that this non-selective strat-
egy should be reserved for people with decompensated liver dis-
ease (Arguedas 2002). Those conflicting cost-effectiveness recom-
mendations do not recognise that non-selective beta-blockers do
not prevent the development of oesophageal varices (Groszmann
2005). Therefore, oesophago-gastro-duodenoscopy remains the
recommended test for the diagnosis and prognosis of oesophageal
varices (Garcia-Tsao 2007; Garcia-Tsao 2008).
In view of the invasive nature and costs of oesophago-gastro-duo-
denoscopy, a non-invasive test with adequate accuracy could serve
as a screening test. Such a test would assist in triaging people be-
fore oesophago-gastro-duodenoscopy, and, if varices of sufficient
risk of bleeding are present, primary prophylaxis will be recom-
mended to prevent variceal haemorrhage. Non-invasive tests for
varices, if sufficiently accurate in detecting high-risk varices, could
even replace oesophago-gastro-duodenoscopy, which is still the
preferred test for diagnosing oesophageal varices. For these rea-
sons, we aimed (1) to assess the ability of platelet count, spleen
length, and platelet count-to-spleen length ratio to triage people
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for oesophago-gastro-duodenoscopy investigation, and (2) to de-
termine whether this approach could replace oesophago-gastro-
duodenoscopy.
O B J E C T I V E S
Primary objectives
To determine the diagnostic accuracy of platelet count, spleen
length, and platelet count-to-spleen length ratio for the diagnosis
of oesophageal varices of any size in paediatric or adult patients
with chronic liver disease or portal vein thrombosis, irrespective of
their aetiology. To investigate the accuracy of these non-invasive
tests as triage or replacement of oesophago-gastro-duodenoscopy.
We considered separately studies with adult participants and stud-
ies with paediatric participants.
Secondary objectives
To compare the diagnostic accuracy of platelet count, spleen
length, and platelet count-to-spleen length ratio for the diagno-
sis of high-risk oesophageal varices in paediatric or adult patients
with chronic liver disease or portal vein thrombosis, irrespective
of aetiology.
We aimed to perform pair-wise comparisons between the three
index tests, while consideringpredefined cut-off values, as reported
in the ’Index test’ section.
We investigated the following sources of heterogeneity.
1. Chronic liver disease compared with portal vein thrombosis.
2. Prevalence of oesophageal varices in the study group (≥
50% versus < 50% for any varices; > 25% versus ≤ 25% for
high-risk varices).
3. Severity of liver disease Child A (> 50% versus ≤ 50%).
4. Different aetiologies (hepatitis C virus (HCV)-associated
cirrhosis versus cirrhosis of all causes).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We aimed to include studies that, irrespective of publication sta-
tus and language, evaluated the diagnostic accuracy of platelet
count, spleen length, and platelet count-to-spleen length ratio for
the diagnosis of oesophageal varices with oesophago-gastro-duo-
denoscopy as the reference standard. We considered studies of
cross-sectional cohort design including people with clinical suspi-
cion of portal hypertension as well as studies of participant-con-
trol design that compared people with oesophageal varices versus
matched controls (Colli 2014a).We excluded studies that analysed
data only per varix rather than per participant unless participant
data were made available by study authors.
Participants
Participants included paediatric or adult patients of any age with
chronic liver disease or portal vein thrombosis, irrespective of ae-
tiology, severity of disease, and duration of illness, in whom the
presence or absence of varices was confirmed by oesophago-gastro-
duodenoscopy. The review focused on diagnostic questions related
to patients who have not yet suffered gastrointestinal bleeding
from oesophageal varices. Patients with a previous surgical portal-
systemic shunt procedure or insertion of a transjugular intrahep-
atic portal-systemic shunt (TIPS), previous ligation or sclerother-
apy of oesophageal varices, previous history of upper gastrointesti-
nal portal hypertensive bleeding, or previous primary prophylac-
tic therapy of variceal haemorrhage make up a distinct group for
whom the diagnosis or natural history of oesophageal varices has
been modified. These patients were not the focus of this review,
hence we excluded studies that included such patients unless in-
vestigators presented data in such a way as to allow this patient
group to be isolated from other included patients.
Index tests
1. Platelet count is obtained from a complete blood count, a
readily available automated clinical test. A platelet count cut-off
value less than 150,000/mm3 is considered thrombocytopenia.
2. Spleen length is usually obtained through evaluation of the
patient’s abdomen by ultrasound scan (USS). Interobserver
agreement when spleen length is determined with USS is
considered excellent. For adults, the upper limit of spleen length
is 130 mm, beyond which the spleen is generally considered
enlarged. Spleen length of 110 mm is regarded as a sensitive cut-
off for exclusion of splenomegaly (Grover 1993). For children,
spleen length is expressed as a standard deviation score relative to
normal values for both age and sex (spleen length z-score)
(Megremis 2004).
3. Platelet count-to-spleen length ratio is a derivative
mathematical model shown to increase the accuracy of both non-
invasive tests for the diagnosis of oesophageal varices. The cut-off
value used most often for adults is 909 (n/mm3)/mm. In
children, platelet count-to-spleen length ratio is calculated using
the spleen length z-score.
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Target conditions
The presence of any oesophageal varices (independent of size)
was detected by oesophago-gastro-duodenoscopy. For secondary
analyses, the target condition considered was the presence of oe-
sophageal varices at high risk of bleeding. High-risk varices were
defined as medium or large varices or small varices with redmarks,
or in patients with decompensated cirrhosis, as assessed by a B-C
Child-Pugh score (Garcia-Tsao 2007). Studies will require at least
one of two target conditions to be identified: the presence of any
oesophageal varices, or the presence of high-risk varices.
Reference standards
Oesophago-gastro-duodenoscopy is the clinical reference standard
test for the diagnosis of oesophageal varices in which the presence
of varices in the oesophagus is directly observed through the endo-
scope. The size and appearance of oesophageal varices are graded
at the time of endoscopy according to one of the systems described
below, and the largest varix identified is used to classify the pa-
tient. Severity of cirrhosis, which is the other factor that defines
bleeding risk, is assessed by Child-Pugh score, with three classes -
A, B, and C - indicating increasing severity (Pugh 1973). Patients
whose largest varix is medium or large or who are included in class
B-C are considered for prophylactic therapy.
1. The Baveno Consensus system differentiates small from
large oesophageal varices (de Franchis 1992), defining small
oesophageal varices as varices that flatten with insufflation during
endoscopy or that minimally protrude into the oesophageal
lumen, and large oesophageal varices as varices that protrude into
the oesophageal lumen and touch each other, or that fill at least
50% of the oesophageal lumen.
2. The Japanese Research Society for Portal Hypertension
used three grades for variceal size (JSPH 1980). Grade 1 varices
collapse with insufflation during endoscopy, grade 2 varices do
not collapse with insufflation and do not occlude the lumen, and
grade 3 varices occlude the lumen. For this review, we will
consider grade 2 as equivalent to medium, and grade 3 as large.
3. The Japanese classification was revised by the Italian Liver
Cirrhosis Project (ILCP) Group (Pagliaro 1988; Zoli 1996),
which describes variceal size as the percentage of the radius of the
oesophageal lumen that is occupied by the largest varix. A small
or grade 1 varix is said to occupy less than 25%, a medium or
grade 2 varix occupies 25% to 50%, and a large or grade 3 varix
occupies greater than 50% of the radius of the lumen of the
oesophagus.
4. The Cales criteria define varices as small if they flatten with
insufflation during endoscopy, medium if they do not flatten
with insufflation, and large if they do not flatten with
insufflation during endoscopy and are confluent (Cales 1990).
5. We will include studies applying alternate classifications if
adequately described and logically defined.
Red marks are usually noted as present or absent and may be
described according to different classifications. Even small varices
showing red marks are classified as ’at high risk of bleeding’.
The interval between index tests and oesophago-gastro-duo-
denoscopy has to be less than 3 months to avoid possible evolu-
tion of the target condition. When a study reported longer time
intervals, we included the study but considered it to be at risk of
bias. Clinically, patients with medium or large oesophageal varices
or with red marks are at greatest risk of haemorrhage; therefore,
we confined secondary analyses to two subgroups: patients with
no varices and small varices compared with patients at high risk.
Search methods for identification of studies
Electronic searches
We searched the Cochrane Hepato-Biliary Group Controlled Tri-
als Register (Gluud 2016), the Cochrane Hepato-Biliary Group
Diagnostic Test of Accuracy Studies Register (Gluud 2016), the
Cochrane Library, MEDLINE (OvidSP), Embase (OvidSP), and
ScienceCitation Index - Expanded (Web of Science) (Royle 2003).
We have presented in Appendix 1 search strategies along with time
spans of the searches. .We applied no language or document-type
restrictions.
Searching other resources
We identified additional references by manually searching the ref-
erences of articles retrieved from computerised databases and rele-
vant review articles. We sought information on unpublished stud-
ies by contacting experts in the field. In addition, we handsearched
abstract books from meetings of the American Association for the
Study of Liver Diseases (AASLD) and the European Association
for the Study of the Liver (EASL) held over the past 10 years.
Data collection and analysis
We followed available guidelines as provided in the Cochrane
Handbook for Diagnostic Test of Accuracy Reviews (DTA Handbook
2010).
Selection of studies
We retrieved publications if they were potentially eligible for in-
clusion on the basis of abstract review, or if they were relevant
review articles for a manual reference search. Two review authors
independently reviewed publications for eligibility. To determine
eligibility, we assessed each publication to determine whether par-
ticipants met the inclusion criteria detailed above. We included
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abstracts only if they provided sufficient data for analysis. We re-
solved disagreements by consensus.
Data extraction and management
Review authors, working in pairs (JCG and JY or AC and GC),
completed a data extraction form for each included study. AC and
GC completed extraction forms for studies retrieved during the
last search (from2009 to2016). Each review author independently
retrieved study data. In cases of discordance, we reached consensus
through discussion.
We retrieved the following data.
1. General information: title, journal, year, publication status,
and study design (prospective vs retrospective).
2. Sample size: number of participants meeting the criteria
and total number of participants screened.
3. Baseline characteristics: baseline diagnosis, age, sex, race,
and disease severity, and medications used concurrently. We
considered severity of liver disease among the studied population
by using the Child-Pugh score (Pugh 1973) and the model for
end-stage liver disease (MELD) in adults (Kamath 2001), and by
using the Child-Pugh score and paediatric end-stage liver disease
(PELD) scores in children (McDiarmid 2002).
4. We reported index tests with all cut-off values.
5. We used the following as clinical reference standard tests:
variceal size, type of classification used, number of endoscopists,
and handling of interobserver error on oesophago-gastro-
duodenoscopy.
6. Numbers of true positive (TP), true negative (TN), false
positive (FP), and false negative (FN) findings. We extracted
these data for each presented cut-off value and for the two target
conditions.
We summarised data from each study in 2 × 2 tables (FP, FN, TP,
TN) according to the two target conditions and entered the data
into Review Manager 5 software.
Missing data
We contacted primary authors by email to ask formissing data that
we needed to build the 2 × 2 tables. When we received no reply,
we sent a second email two weeks later. When we still received no
reply, we excluded the study.
Assessment of methodological quality
Two review authors independently assessed the risk of bias of in-
cluded studies using QUADAS-2 (revised tool for quality assess-
ment of diagnostic accuracy studies) domains (Whiting 2011).
In cases of discordance, we reached a consensus through discus-
sion. We adopted the domains in Appendix 2 to address aspects
of study quality involving the participant spectrum, index tests,
target conditions, reference standards, and flow and timing. We
did not plan to consider blinding of the index test to results of the
reference standard for cases in which platelet count is obtained by
an automated counter. We classified a study as having high risk of
bias if we judged study to have high risk of bias or unclear risk of
bias in at least one of the domains of QUADAS-2.
Statistical analysis and data synthesis
We carried out statistical analyses according to recommendations
provided in the Cochrane Handbook for Systematic Reviews of Di-
agnostic Test Accuracy (DTA Handbook 2010).
We built 2 × 2 tables (TP, TN, FP, FN) for each primary study for
the three index tests for the two target conditions (any varices and
high-risk varices). We considered studies with adult participants
and studies with paediatric participants separately, as we retrieved
only studies that included only adult or paediatric participants.
For all combinations of index test/target condition/participants,
we followed the following strategy of analysis. First, we performed a
graphical descriptive analysis of the included studies: We reported
forest plots (sensitivity and specificity separately, with their 95%
confidence intervals (CIs)), and we provided a graphical represen-
tation of studies in the receiver operating characteristic (ROC)
space (sensitivity against 1 - specificity). Second, we performed a
meta-analysis. When primary studies reported accuracy estimates
of an index test using different cut-off points, we used the hier-
archical summary ROC model (HSROC) to pool data (sensitivi-
ties and specificities) and to plot a summary ROC (SROC) curve
(Rutter 2001). When considering studies with a common cut-off
value, we used the bivariate model and provided estimates of sum-
mary sensitivity and specificity.We used pooled estimates obtained
from the fitted models to calculate summary estimates of positive
and negative likelihood ratios (LR+ and LR-, respectively).
For primary studies that reported accuracy results for more than
one cut-off point, we reported sensitivities and specificities for all
cut-off points, but we used a single cut-off point for each study in
HSROC (or bivariate) analysis.
We made pair-wise comparisons between tests by adding a covari-
ate for the index test to the HSROC (for comparisons of SROC
curves) or bivariate (for comparisons of sensitivity and specificity
at fixed cut-off value) model. We assessed the significance of dif-
ferences in test accuracy by using the log-likelihood ratio test for
comparison of models with and without the index test covariate
term. We performed both indirect and direct comparisons, if suf-
ficient data were available.
We considered P values less than 0.05 as two-sided and statistically
significant.
We performed all statistical analyses using SAS statistical soft-
ware, release 9.4 (SAS Institute Inc., Cary, NC, USA) and macro
METADAS (DTA Handbook 2010).
Investigations of heterogeneity
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We investigated effects of the following predefined sources of het-
erogeneity.
1. Chronic liver disease compared with portal vein thrombosis.
2. Prevalence of oesophageal varices in the study group (≥
50% versus < 50% for any varices; > 25% versus ≤ 25% for
high-risk varices).
3. Severity of liver disease Child A (> 50% versus ≤ 50%).
4. Different aetiologies (HCV-associated cirrhosis versus all
aetiologies),
by adding covariates to the bivariate or to theHSROC.We assessed
the statistical significance of the covariate effect by using the log-
likelihood ratio test for comparison of models with and without
the covariate term.
To limit the number of statistical analyses, we investigated sources
of heterogeneity by considering only studies with the cut-off value
defined in the “Index test” section.
Sensitivity analyses
We attempted to assess effects of risk of bias of included studies
on diagnostic accuracy by performing a sensitivity analysisfrom
which we excluded studies with the following characteristics.
1. Studies classified at high risk of bias. We classified a study as
having high risk of bias if we judged study to have high risk of
bias or unclear risk of bias in at least one of the domains of
QUADAS-2 (Appendix 2). In addition, we identified the two
following signalling questions as most relevant, and we decided
to assess them in separate sensitivity analyses.
i) “Was a case-control design avoided?”
ii) “If a threshold was used, was it prespecified?”
2. Studies published only in abstract/letter form.
To limit the number of statistical analyses, we performed sensitivity
analyses by considering only studies with the cut-off value defined
in the “Index test” section.
R E S U L T S
Results of the search
We ran the search on 14 June 2016. We identified 3832 references
by searching the following databases: the Cochrane Hepato-Bil-
iary Group ControlledTrials Register (n = 17), theCochraneHep-
ato-Biliary Group Diagnostic Test Accuracy Register (n = 8), the
Cochrane Library (n = 73), MEDLINE (OvidSP) (n = 943), Em-
base (OvidSP) (n = 2188), and Science Citation Index - Expanded
(Web of Science) (n = 603). After exclusion of 1172 duplicates,
2660 references remained for possible eligibility. We retrieved five
additional references through handsearching. After reading the ti-
tle and the abstract of these 2665 references, we excluded 2566 of
them, as they did not meet the inclusion criteria. We retrieved full
texts of the remaining 99 records, and after reading the full texts,
we excluded 34 studies for various reasons (see Characteristics of
excluded studies). Finally, we included in our review 65 references
reporting data on 71 studies (Figure 1).
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Figure 1. Study flow diagram.
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We reported in the Characteristics of included studies tables the
main characteristics of the 71 included studies. Investigators re-
ported five studies (Primignani 2002; Lei 2007; Aqodad 2011;
El Ray 2015; Wang CC 2015) only in abstract form and three
(Zimbwa 2004; Sen 2008a; Sen 2008b) as letters. Four stud-
ies (Colecchia 2011; Gana 2011; Alcantara 2012; Adami 2013)
included only paediatric participants, and the other 67 stud-
ies included only adult participants. All included studies were
cross-sectional studies, prospective or retrospective, conducted at
tertiary referral centres. Sixteen studies (Madhotra 2002; Baig
2008; Parrino 2008; Sen 2008a; Sen 2008b; Sarangapani 2010;
Schwarzenberger 2010; Cherian 2011; Colecchia 2011; Colecchia
2012; Esmat 2012; Mahassadi 2012a; Mahassadi 2012b; Adami
2013;Chiodi 2014;Grgurevic 2014) assessed the accuracy ofmore
than one index test on the same participants. The number of par-
ticipants enrolled in each of the 71 included studies ranged from
31 to 1016 (median = 111). Eight studies included only partic-
ipants in Child-Pugh class A, three studies did not include any
participant in Child-Pugh class A, and 26 studies did not report
Child-Pugh classification.
Methodological quality of included studies
We have reported in detail results of the quality assessment of
included studies in the Characteristics of included studies tables,
and we have summarised this information in Figure 2 and Figure
3.
Figure 2. Methodological quality of the 71 included studies.
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Figure 3. Quality assessment summary: review authors’ judgements about each risk of bias item for each
included study.Not all of the included studies considered all three index tests. Cells are empty when an index
test was not considered in a study.
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Patient selection
All 71 studies were cross-sectional: 29 studies were prospec-
tive, 21 were retrospective, and, in 21 studies, it was not clear
whether a prospective or retrospective design was adopted. Thirty-
four studies reported that they enrolled consecutive participants;
six studies reported non-consecutive enrolment of participants
(Sebastiani 2010; Wang HM 2012; Grgurevic 2014; Wang CC
2015; Abd-Elsalam 2016b; Sheta 2016); for the remaining 31
studies, this information was unclear. The authors of three stud-
ies did not avoid inappropriate exclusions (Giannini 2005; Sanyal
2006; Karatzas 2016): One study included only people with pre-
vious negative screening for oesophageal varices who regularly at-
tended an outpatient clinic and excluded the others (Giannini
2005); one study excluded patients with contraindications for
computerised tomography, which was one of the index tests con-
sidered in that study (Karatzas 2016); one study included only
participants from an interventional randomised clinical trial ac-
cording to the exclusion criteria of this trial (Sanyal 2006). In
eight other studies, information about exclusions was unclear. In
summary, we classified nine studies as having high risk of bias, 30
studies unclear risk of bias, and 32 low risk of bias for the patient
selection domain.
We had high concern regarding patient selection in seven stud-
ies, as they included mainly participants with advanced and de-
compensated disease (Zaman 2001; Burton 2007d; Agha 2009;
Barikbin 2010; Abu 2011; Agha 2011; Grgurevic 2014); we had
unclear concern about three studies that did not report a definition
for severity of liver disease (Sarangapani 2010; Aqodad 2011; El
Ray 2015).
Index tests
Platelet count: We considered 11 studies to have low risk of bias,
and 26 to have high risk of bias.
Spleen length: We considered three studies to have low risk of
bias, and 12 to have high risk of bias as the threshold value was
not predefined and/or blind interpretation of results was not en-
sured (Primignani 2002; Jeon 2006; Baig 2008; Parrino 2008;
Sen 2008a; Sen 2008b; Sarangapani 2010; Cherian 2011; Esmat
2012; Mahassadi 2012a; Grgurevic 2014; Wang CC 2015). One
study provided a predefined cut-off value but blinding presented
unclear risk of bias (Madhotra 2002).
Platelet count-to-spleen length ratio: We considered seven studies
to have low risk of bias, 22 high risk of bias, and 14 unclear risk
of bias as the threshold value was not predefined and/or blind
interpretation of results was not clearly ensured.
We had no applicability concerns.
Reference standards
All studies used an acceptable reference standard: gastrointestinal
endoscopy with varices graded according to a recognised common
scoring system.We had some concerns regarding blinded (without
knowledge of results of the index tests) interpretation of the refer-
ence standard. Investigators in 23 studies reported that reference
standard results were interpreted without knowledge of the results,
and 48 studies provided unclear information on this. On the basis
of these results, we classified 48 studies as having unclear risk of
bias and 23 as having low risk of bias for the reference standard
domain. We had no concerns regarding applicability.
Flow and timing
All participants underwent the same reference standard in all stud-
ies. The time interval between the index test and the reference
standard execution was appropriate (i.e. < 3 months) in 34 stud-
ies, was inappropriate in one study (Ding 2016; time interval < 6
months), and was not reported in the remaining 36 studies.
Eleven studies excluded some participants from the analysis. Rea-
sons reported by study authors included incomplete information,
participants lost to follow-up, and participants who did not un-
dergo the reference standard or the index test. On the basis of
these results, we classified 12 studies as having high risk of bias,
32 unclear risk of bias, and 27 low risk of bias for the flow and
timing domain.
Overall assessment
Only one study was at low risk of bias in all four QUADAS-2
domains (Giannini 2006). We classified 52 studies as having high
risk of bias in at least one domain. We judged the remaining 18
studies as having unclear risk of bias.
Funding
Sebastiani 2010 reported under “Financial support” that the first
study author “... is funded by an unrestricted grant from Roche-
Italia”.
Sanyal 2006 reported under “Disclosures” that “This study was
supported by the National Institute of Diabetes and Digestive and
Kidney Diseases (contract numbers are listed below). Additional
support was provided by the National Institute of Allergy and
Infectious Diseases, the National Cancer Institute, the National
Center for Minority Health and Health Disparities, and by Gen-
eral Clinical Research Center grants from the National Center for
Research Resources, National Institutes of Health (grant numbers
are listed below). Additional funding to conduct this study was
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supplied by Hoffmann-La Roche, Inc, through a Cooperative Re-
search and Development Agreement with the National Institutes
of Health”.
Eighteen studies reported that they received no funding. The re-
maining 51 studies provided no information on funding.
Findings
Adult participants - any varices
Platelet count for any varices
Any cut-off value
Twenty-five studies with 5096 participants provided data assess-
ing platelet count for the presence of any varices. The median
prevalence of the target disease was 57% (range 26% to 88%).
Cut-off values ranged from 82,000 to 150,000/mm3 . Sensitivity
of platelet count for the diagnosis of oesophageal varices of any
size ranged from 0.37 to 0.92, and specificity ranged from 0.39 to
0.98 (Figure 4).
Figure 4. Forest plot. Adult participants - platelet count - any varices.
We then carried out three meta-analyses that included only studies
that reported a cut-off value of around 100,000/mm3 , around
120,000/mm3 , and around 150,000/mm3 .
Cut-off value around 100,000/mm3
Eleven studies with 3506 participants provided data using a cut-
off value of around 100,000/mm3 (range 90,000 to 110,000/mm
3). Sensitivity of the 11 studies varied from 0.37 to 0.80, and
specificity from 0.60 to 0.91 (Figure 5). By using the bivariate
model, we obtained the following estimates: sensitivity 0.57 (95%
CI 0.50 to 0.64), specificity 0.75 (95% CI 0.67 to 0.82), LR+ 2.3
(95% CI 1.7 to 3.1), and LR- 0.57 (95% CI 0.49 to 0.67) (Figure
6).
14Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic
liver disease or portal vein thrombosis (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 5. Forest plots. Adult participants - platetelet count - various cut-off values - any varices.
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Figure 6. Studies in the ROC space. Adult participants - platelet count - various cut-off values - any varices.
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Cut-off value around 120,000/mm3
Seven studies with 815 participants provided data using a cut-off
value of around 120,000/mm3 (range 117,000 to 132,000/mm
3). Sensitivity of the seven studies varied from 0.67 to 0.84, and
specificity from 0.39 to 0.83 (Figure 5). By using the bivariate
model, we obtained the following estimates: sensitivity 0.77 (95%
CI 0.72 to 0.81), specificity 0.69 (95% CI 0.57 to 0.78), LR+ 2.4
(95% CI 1.7 to 3.5), and LR- 0.34 (95% CI 0.26 to 0.44) (Figure
6).
Cut-off value around 150,000/mm3
Ten studies with 2054 participants provided data using a cut-off
value of around 150,000/mm3 (range 140,000 to 150,000/mm
3). Sensitivity of the 10 studies varied from 0.56 to 0.92, and
specificity from 0.52 to 0.98 (Figure 5). By using the bivariate
model, we obtained the following estimates: sensitivity 0.71 (95%
CI 0.63 to 0.77), specificity 0.80 (95% CI 0.69 to 0.88), LR+ 3.6
(95% CI 2.4 to 5.4), and LR- 0.37 (95% CI 0.30 to 0.45) (Figure
6).
Heterogeneity analysis
We investigated heterogeneity while considering only studies with
a cut-off value of around 150,000/mm3 - the predefined cut-off
value. We found no effect of prevalence of varices (≤ 50% vs >
50%) or Child A on accuracy. We found an effect of aetiology (P
= 0.036). Sensitivity and specificity were 0.76 (95% CI 0.60 to
0.86) and 0.63 (0.59 to 0.67) for the four studies that included
only participants with HCV. Sensitivity and specificity were 0.71
(95% CI 0.66 to 0.76) and 0.88 (95% CI 0.83 to 0.91) for the
four studies that included participants with mixed aetiology.
Sensitivity analysis
When considering Zein 2004b, Levy 2007b, Colecchia 2012, and
Abd-Elsalam 2016b, with a prespecified cut-off value among all
studies of around 150,000/mm3 , we obtained sensitivity of 0.74
(95% CI 0.57 to 0.86) and specificity of 0.78 (95% CI 0.57 to
0.90). We could not perform the remaining sensitivity analyses,
as all studies were cross-sectional, all were at high/unclear risk of
bias, and all were published as full text.
Spleen length for any varices
Any cut-off value
Thirteen studies with 1489 participants provided data on assess-
ment of spleen length for the presence of any varices. The median
prevalence of the target disease was 62% (range 17% to 82%).
Sensitivity of the 13 studies varied from 0.40 to 0.96, and speci-
ficity from 0.48 to 0.98. Cut-off values ranged from 107 to 150
mm (Figure 7). We included in this analysis one study reporting
data on two cut-offs (110 mm and 150 mm) by using only the
cut-off of 150 mm (Colecchia 2012).
Figure 7. Forest plot. Adult participants - spleen length - any varices.
Cut-off value around 110 mm
Five studies with 594 participants reported data using a cut-off
value of around 110 mm (range 110 to 112.5 mm). Sensitivity
of the five studies varied from 0.75 to 0.96, and specificity from
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0.43 to 0.68 (Figure 8). By using the bivariate model, we obtained
the following estimates: sensitivity 0.85 (95% CI 0.75 to 0.91),
specificity 0.54 (95% CI 0.46 to 0.62), LR+ 1.8 (95% CI 1.6 to
2.1), and LR- 0.28 (95% CI 0.17 to 0.44) (Figure 9).
Figure 8. Forest plots. Adult participants - spleen length - any varices: various cut-off values.
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Figure 9. Studies in the ROC space. Adult participants - spleen length - any varices: various cut-off values.
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Cut-off value around 150 mm
FIve studies with 598 participants reported data using a cut-off
value of around 150 mm (range 140 to 150 mm). Sensitivity of
the five studies varied from 0.40 to 0.81, and specificity from
0.64 to 0.96 (Figure 8). By using the bivariate model, we obtained
the following estimates: sensitivity 0.57 (95% CI 0.41 to 0.71),
specificity 0.82 (95% CI 0.72 to 0.89), LR+ 3.2 (95% CI 2.3 to
4.4), and LR- 0.53 (95% CI 0.39 to 0.72) (Figure 9).
Heterogeneity analysis
We could not assess effects of sources of heterogeneity among
studies with a cut-off value around 110 mm, as the models failed
to converge owing to the small number of studies.
Sensitivity analysis
In considering studies with a cut-off value of around 110 mm,
when we excluded the two studies reported only in abstract form,
we obtained sensitivity of 0.84 (95% CI 0.71 to 0.92) and speci-
ficity of 0.58 (95% CI 0.43 to 0.71) (Primignani 2002; Wang CC
2015). We could not perform the remaining sensitivity analyses
because all studies were cross-sectional and were at high/unclear
risk of bias, and all but one of the studies used a prespecified cut-
off value.
Platelet count-to-spleen length ratio for any varices
Any cut-off value
Thirty-eight studies with 5235 participants provided data on as-
sessment of platelet count to spleen length for the presence of
varices of any size. The median prevalence of varices was 65%
(range 28% to 85%). Sensitivity of the 38 studies varied from 0.40
to 1.00, and specificity from 0.36 to 1.00. Cut-off values ranged
from 420 to 1847 (n/mm3)/mm (Figure 10).
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Figure 10. Forest plot. Adult participants - platelet count-to-spleen length ratio - any varices.
We then carried out a meta-analysis including only studies that
reported a cut-off value of 909 (n/mm3)/mm.
Cut-off value of 909 (n/mm3)/mm
Seventeen studies with 2637 participants provided data using a
cut-off value of 909 (n/mm3)/mm. Sensitivity of the 17 studies
varied from 0.40 to 1.00, and specificity from 0.42 to 1.00. By
using the bivariate model, we obtained the following estimates:
sensitivity 0.93 (95% CI 0.83 to 0.97), specificity 0.84 (95% CI
0.75 to 0.91), LR+ 5.9 (95% CI 3.5 to 9.9), and LR- 0.09 (95%
CI 0.03 to 0.22) (Figure 11).
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Figure 11. Studies in the ROC space. Adult participants - platelet count-to-spleen length ratio. Only studies
with a cut-off value of 909 (n/mm3)/mm - any varices.
Heterogeneity analysis
We investigated effects of sources of heterogeneity among studies
using a cut-off value of 909 (n/mm3)/mm. We found no effect of
prevalence of varices, of prevalence of Child A participants, or of
aetiology.
Sensitivity analysis
We could not perform the remaining sensitivity analyses, as all
studies were cross-sectional, all but one were at high/unclear risk
of bias (Giannini 2006), all but one were published as full text
(Zimbwa 2004), and all but one used a prespecified cut-off value
(Giannini 2003a).
Comparative analysis of tests for any varices
Platelet count compared with spleen length
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Wecompared the accuracy of platelet count (25 studies) and spleen
length (13 studies) for the presence of any varices (Figure 12)
among all included studies (indirect comparisons) using varying
cut-off values. The HSROC model analysis showed a statistically
significant result (P = 0.001), suggesting higher overall accuracy
of the platelet count test.
Figure 12. Indirect comparison. Forest plot. Adult participants - platelet count compared with spleen
length - any varices.
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When we compared the 10 studies that reported a cut-off value of
150,000/mm3 for platelet count with the five studies that reported
a cut-off value of around 110 mm for spleen length (indirect com-
parison; Figure 13), we observed higher accuracy of platelet count
(P = 0.021; Figure 14; Table 1).
Figure 13. Forest plot. Indirect comparison. Adult participants - platelet count (cut-off around 150,000)
compared with spleen length (cut-off around 110 mm) - any varices.
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Figure 14. Indirect comparison. Studies in the ROC space. Adult participants - platelet count (cut-off
around 150,000) compared with spleen length (cut-off around 110 mm) - any varices.
25Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic
liver disease or portal vein thrombosis (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Platelet count compared with platelet count-to-spleen length
ratio
We compared the accuracy of platelet count (25 studies) and
platelet count-to-spleen length ratio (38 studies) for the presence
of any varices among all included studies (indirect comparisons;
Figure 15) using varying cut-off values. The HSROCmodel anal-
ysis showed a statistically significant result (P < 0.001), suggest-
ing higher overall accuracy of the platelet count-to-spleen length
ratio test. We performed HSROC analysis that was limited to
the 10 studies reporting data on both index tests (Figure 16); we
again found a statistically significant result favouring the ratio (P
= 0.007; direct comparisons).
26Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic
liver disease or portal vein thrombosis (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 15. Indirect comparison. Forest plots. Adult participants - platelet count compared with platelet
count-to-spleen length ratio - any varices.
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Figure 16. Direct comparison. Forest plots. Adult participants - platelet count compared with platelet
count-to-spleen length ratio - any varices.
On the contrary, when we compared the 17 studies that reported
a cut-off value of 909 (n/mm3)/mm for platelet count-to-spleen
length ratio with the 10 studies that reported a cut-off value of
around 150,000/mm3 for platelet count (indirect comparison;
Figure 17), we observed a non-statistically significant result (P
= 0.252; Figure 18; Table 1). Only one study (Colecchia 2012)
provided data for direct comparison.
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Figure 17. Indirect comparison. Forest plots. Adult participants - platelet count (cut-off around
150.000/mm3) compared with platelet count-to-spleen length ratio (cut-off 909 (n/mm3)/mm) - any varices.
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Figure 18. Indirect comparison. Studies in the ROC space. Adult participants - platelet count (cut-off
around 150.000) compared with platelet count-to-spleen length ratio (cut-off 909 (n/mm3)/mm) - any varices.
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Platelet count-to-spleen length ratio compared with spleen
length
We compared the accuracy of platelet count-to-spleen length ra-
tio (38 studies) and spleen length (13 studies) for the presence
of any varices among all included studies (indirect comparisons;
Figure 19) using varying cut-off values. The HSROCmodel anal-
ysis showed a statistically significant result (P < 0.001), suggesting
higher overall accuracy of the platelet count-to-spleen length ratio
test .
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Figure 19. Indirect comparison. Forest plots. Adult participants - platelet count-to-spleen length ratio
compared with spleen length - any varices.
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When we compared the 17 studies that reported a cut-off value of
909 (n/mm3)/mm for platelet count-to-spleen length ratio with
the five studies that reported a cut-off value of around 110 mm
for spleen length (indirect comparison; Figure 20), we observed
higher accuracy of platelet count-to-spleen length ratio (P < 0.001;
Figure 21; Table 1).
Figure 20. Indirect comparison. Forest plots. Adult participants - platelet count-to-spleen length ratio (cut-
off 909 (n/mm3)/mm) compared with spleen length (cut-off around 110) - any varices.
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Figure 21. Indirect comparison. Studies in the ROC space. Adult participants - platelet count-to-spleen
length ratio (cut-off 909 (n/mm3)/mm) compared with spleen length (cut-off around 110 mm) - any varices.
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Adult participants - high-risk varices
Platelet count for high-risk varices
Twenty-one studies with 4266 participants provided data on as-
sessment of platelet count for the presence of high-risk varices.
The median prevalence of high-risk varices was 20% (range 4% to
70%). Sensitivity of the 21 studies varied from 0.33 to 1.00, and
specificity from 0.39 to 0.87. Cut-off values ranged from 68,000/
mm3 to 160,000/mm3 (Figure 22). We fitted the HSROC model
to the 21 studies, and we obtained an estimate of the SROC curve.
Figure 22. Forest plot. Adult participants - platelet count - high-risk varices.
We carried out two meta-analyses including only studies that
reported a cut-off value of around 90,000/mm3 and around
150,000/mm3 (Figure 23).
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Figure 23. Forest plots. Adult participants - platelet count - various cut-off values - high-risk varices.
Cut-off value of around 90,000/mm3
Eleven studies with 3084 participants provided data using a cut-
off value of around 90,000/mm3 (range 80,000 to 100,000/mm
3). Sensitivity of the 11 studies varied from 0.33 to 1.00, and
specificity from 0.55 to 0.87. By using the bivariate model, we
obtained the following estimates: sensitivity 0.59 (95% CI 0.54
to 0.64), specificity 0.72 (95% CI 0.66 to 0.78), LR+ 2.1 (95%
CI 1.8 to 2.6), and LR- 0.57 (95% CI 0.52 to 0.63) (Figure 24).
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Figure 24. Studies in the ROC space. Adult participants - platelet count - various cut-off values - high-risk
varices.
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Cut-off value of around 150,000/mm3
Seven studies with 1671 participants provided data using a cut-off
value of around 150,000/mm3 (range 140,000 to 160,000/mm
3). Sensitivity of the seven studies varied from 0.73 to 0.90, and
specificity from 0.39 to 0.82. By using the bivariate model, we
obtained the following estimates: sensitivity 0.80 (95% CI 0.73
to 0.85), specificity 0.68 (95% CI 0.57 to 0.77), LR+ 2.5 (95%
CI 1.8 to 3.3), and LR- 0.30 (95% CI 0.23 to 0.39) (Figure 24).
Heterogeneity analysis
We could not assess effects of sources of heterogeneity among
studies with a cut-off value of around 150,000/mm3 , as themodels
failed to converge owing to the small number of studies.
Sensitivity analysis
For studies with a cut-off value of around 150,000/mm3 , we could
not perform the sensitivity analysis, as all studies were cross-sec-
tional, all were at high/unclear risk of bias, all were published as
full text, and only two reported a prespecified cut-off value.
Spleen length for high-risk varices
Six studies with 883 participants provided data on assessmentof
spleen length for the presence of high-risk varices. The median
prevalence of high-risk varices was 42% (range 13% to 70%). Sen-
sitivity of the six studies varied from 0.50 to 0.88, and specificity
from 0.55 to 0.84. Cut-off values ranged from 120 mm to 160
mm (Figure 25). We used the HSROC model to obtain an esti-
mate of the SROC curve.
Figure 25. Forest plot. Adult participants - spleen length - high-risk varices.
Heterogeneity analysis
We found no effects of aetiology. We could not assess effects of
Child A and of prevalence of varices, as the models failed to con-
verge owing to the small number of studies.
Sensitivity analysis
We could not perform sensitivity analyses because all studies were
cross-sectional, all were at high/unclear risk of bias, all were pub-
lished as full text, and only two reported a prespecified cut-off
value.
Platelet count-to-spleen length ratio for high-risk varices
Ten studies with 930 participants provided data for assessment
of platelet count-to-spleen length ratio for the presence of high-
risk varices. The median prevalence of high-risk varices was 47%
(range 15% to 70%). Sensitivity of the 10 studies varied from 0.50
to 1.00, and specificity from 0.29 to 0.84. Cut-off values ranged
from 870 to 1372 (n/mm3)/mm.(Figure 26).
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Figure 26. Forest plot. Adult participants - platelet count-to-spleen length ratio - high-risk varices.
Cut-off value of around 909 (n/mm3)/mm
Seven studies with 642 participants provided data with a cut-off
value of around 909 (n/mm3)/mm (range 897 to 921 n/mm3/
mm; Figure 27). Sensitivity of the seven studies varied from 0.50
to 0.97, and specificity from 0.40 to 0.84. By using the bivariate
model, we obtained the following estimates: sensitivity 0.85 (95%
CI 0.72 to 0.93), specificity 0.66 (95% CI 0.52 to 0.77), LR+ 2.5
(95% CI 1.8 to 3.4), and LR- 0.22 (95% CI 0.12 to 0.42) (Figure
28).
Figure 27. Forest plot. Adult participants - platelet count-to-spleen length ratio - cut-off around 909
(n/mm3)/mm - high-risk varices.
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Figure 28. Studies in the ROC space. Adult participants - platelet count-to-spleen length ratio - cut-off
around 909 (n/mm3)/mm - high-risk varices.
Heterogeneity analysis
We investigated effects of sources of heterogeneity among studies
with a cut-off value of 909 (n/mm3)/mm. We found no effect of
prevalence of varices nor of aetiology.We could not assess the effect
of Child A (≤ 50% vs > 50%), as the models failed to converge
owing to the small number of studies.
Sensitivity analysis
Among studies with a cut-off value of around 909 (n/mm3)/mm,
and when considering only those that reported a prespecified cut-
off value, we obtained sensitivity of 0.82 (95% CI 0.55 to 0.94)
and specificity of 0.71 (95% CI 0.49 to 0.86). We could not
perform the remaining sensitivity analyses because all studies were
cross-sectional, all were at high/unclear risk of bias, and all were
published as full text.
Comparative analysis of tests for high-risk varices
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Platelet count compared with spleen length
We fitted the HSROC model to compare the accuracy of platelet
count (21 studies) and spleen length (six studies) for the presence of
high-risk varices among all included studies (indirect comparisons;
Figure 29), irrespective of the cut-off value. We observed a non-
statistically significant result (P = 0.304).
Figure 29. Indirect comparison. Forest plot. Adult participants - platelet count compared with spleen
length - high-risk varices.
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Platelet count compared with platelet count-to-spleen length
ratio
We compared the accuracy of platelet count (21 studies) and
platelet count-to-spleen length ratio (10 studies) for the presence
of high-risk varices among all included studies (indirect compar-
isons; Figure 30). The HSROC model analysis showed a statisti-
cally significant result (P = 0.003), suggesting higher overall ac-
curacy of platelet count-to-spleen length ratio. We confirmed this
result when we performed HSROC analysis limited to the five
studies reporting data on both index tests (direct comparisons; P
= 0.034) (Figure 31).
Figure 30. Indirect comparison. Forest plots. Adult participants - platelet count compared with platelet
count-to-spleen length ratio - high-risk varices.
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Figure 31. Direct comparison. Forest plots. Adult participants - platelet count compared with platelet
count-to-spleen length ratio - high-risk varices.
When we compared the seven studies that reported a cut-off value
of 909 (n/mm3)/mm for platelet count-to-spleen length ratio with
the seven studies that reported a cut-off value of 150,000/mm3 for
platelet count, we observed a non-statistically significant result (in-
direct comparison, bivariate model; P = 0.638) (Figure 32; Figure
33). Only one study reported data on both tests (Sarangapani
2010).
Figure 32. Indirect comparison. Forest plots. Adult participants - platelet count (cut-off around
150.000/mm3) compared with platelet count-to-spleen length ratio (cut-off 909 (n/mm3)/mm) - high-risk
varices.
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Figure 33. Indirect comparison. Studies in the ROC space. Adult participants - platelet count (cut-off
around 150,000/mm3) compared with platelet count-to-spleen length ratio (cut-off 909 (n/mm3)/mm) - high-
risk varices.
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Platelet count-to-spleen length ratio compared with spleen
length
Finally, when we compared the accuracy of spleen length (six stud-
ies) and platelet count-to-spleen length ratio (10 studies) for the
presence of high-risk varices among all included studies (indirect
comparisons; Figure 34), we observed a statistically significant dif-
ference between the two tests (P < 0.001), suggesting higher ac-
curacy of platelet count-to-spleen length ratio.
Figure 34. Indirect comparison. Forest plots. Adult participants - platelet count-to-spleen length ratio
compared with spleen length - high-risk varices.
Paediatric participants - any varices
We found four studies including 277 paediatric participants with
different types of liver disease and/or portal vein thrombosis (
Colecchia 2011; Gana 2011; Alcantara 2012; Adami 2013).
Platelet count for any varices
Four studies with 277 paediatric participants provided data on
assessment of platelet count for the presence of any varices. Cut-off
values used by the four studies were 115,000/mm3 (three studies)
and 119,000/mm3 (one study). Sensitivity of platelet count for
diagnosis of oesophageal varices of any size ranged from 0.53 to
0.81, and specificity from 0.71 to 0.94 (Figure 35). We fitted the
bivariate model to the four studies, and we obtained the following
estimates: sensitivity 0.71 (95% CI 0.60 to 0.80), specificity 0.83
(95% CI 0.70 to 0.91), LR+ 4.2 (95% CI 2.4 to 7.3), and LR-
0.35 (95% CI 0.25 to 0.48).
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Figure 35. Forest plot. Paediatric participants - platelet count - any varices.
Spleen length z-score for any varices
We found no studies reporting results of spleen length z-score for
any varices.
Platelet count-to-spleen length z-score ratio for any varices
Two studies with 197 paediatric participants provided data on
assessment of platelet count-to-spleen length ratio for the presence
of any varices. Cut-off values used by the two studies were 24 and
25. Sensitivities reported by the two studies were 0.69 and 0.82,
and specificities 0.79 and 0.53 (Figure 36). We fitted the bivariate
model, and we obtained the following estimates: sensitivity 0.74
(95% CI 0.65 to 0.81), specificity 0.64 (95% CI 0.36 to 0.85),
LR+ 2.0 (95% CI 1.0 to 4.0), and LR- 0.41 (95% CI 0.27 to
0.61).
Figure 36. Forest plot. Paediatric participants - platelet count-to-spleen length z-score ratio - any varices.
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Summary of findings
Review question What is the diagnostic accuracy of platelet count for the diagnosis of oesophageal varices in adults with liver disease or portal vein thrombosis?
Population Adults with diagnosis of chronic liver disease or portal vein thrombosis. Age ≥ 18 years
Settings Outpat ients and inpat ients in secondary/ tert iary care sett ing
Study design Prospect ive and retrospect ive cross-sect ional studies. No case-control studies were found
Index tests Platelet count
Reference standards Upper endoscopy







Implications in a hypo-
thetical cohort of 1000
people
Post- test probability Quality and comments
Any varices
Cut-of f value: around
150,000 / mm3 (range
140,000 to 150,000/
mm3)
Sensit ivity 0.71 (0.63 to
0.77)






2054 part icipants (10) 38%
(25% to 79%)
With a prevalence of
38%, 380 out of 1000
people will have varices
of any size. Of these
380 people, 110 (29%




ate prophylaxis or fol-
low-up
The remaining 620 peo-




• If test posit ive:
69%
• If test negat ive:
18%
Most studies are at high
risk of bias
No predef init ion of cut-
of f value of the index
test for most studies
Median prevalence of










































































































































































124 people (20% of
620) will receive false
diagnosis of varices
and will undergo an un-
necessary endoscopy
High risk varices
Cut-of f value: around
150,000 / mm3 (range
140,000 to 160,000/
mm3)
Sensit ivity 0.80 (0.73 to
0.85)






1671 part icipants (7) 20%
(6% to 48%)
With a prevalence of
20%, 200 out of 1000
people will have varices
at high risk of bleeding.
Of these 200 people,
40 (20% of 200) people
with high-risk varices
will receive misdiagno-
sis and will not receive
ef fect ive prophylaxis
The remaining 800 peo-
ple will not have high-
risk varices. 256 peo-
ple (32% of 800) will
receive false diagnosis
of high-risk varices and





• If test posit ive:
38%
• If test negat ive:
7%
Most or all studies at
high risk of bias
No predef init ion of cut-
of f value of the index






































































































































































Review question What is the diagnostic accuracy of spleen length for the diagnosis of oesophageal varices in adult people with liver disease or portal vein
thrombosis?
Population Adults with diagnosis of chronic liver disease or portal vein thrombosis. Age ≥ 18 years
Settings Outpat ients and inpat ients in secondary/ tert iary care sett ing
Study design Prospect ive and retrospect ive cross-sect ional studies. No case-control studies were found
Index tests Spleen length
Reference standards Upper endoscopy







Implications in a hypo-
thetical cohort of 1000
people
Post- test probability Quality and comments
Any varices
Cut-of f value: around
110 mm (range 110 to
112.5 mm)
Sensit ivity 0.85 (0.75 to
0.91)
Specif icity 0.54 (0.46 to
0.62)
LR+ 1.8 (1.6 to 1.21)
LR- 0.28 (0.17 to 0.44)
594 part icipants (5) 53%
(17% to 71%)
With a prevalence of
53%, 530 out of 1000
people will have varices
of any size. Of these
530 people, 80 (15%






The remaining 470 peo-
ple will have no varices.




• If test posit ive:
67%
• If test negat ive:
24%
Most or all studies at






































































































































































470) will receive false
diagnosis of varices
and will undergo an un-
necessary endoscopy
High- risk varices
Cut-of f value: no com-
mon cut-of f value.
Range 120 to 160 mm
Sensit ivity ranged f rom
0.50 to 0.88 and speci-
f icity f rom 0.55 to 0.84
883 part icipants (6) 42%
(13% to 70%)
Inconsistency of re-
sults (no common cut-
of f value) prevents any
conclusions
.
Most or all studies at






































































































































































What is the diagnostic accuracy of platelet count- to-spleen length ratio?
Review question What is the diagnostic accuracy of platelet count- to-spleen length ratio for the diagnosis of oesophageal varices in adult people with liver disease
or portal vein thrombosis?
Population Adults with diagnosis of chronic liver disease or portal vein thrombosis. Age ≥ 18 years
Settings Outpat ients and inpat ients in secondary/ tert iary care sett ing
Study design Prospect ive and retrospect ive cross-sect ional studies. No case-control studies were found
Index tests Platelet count-to-spleen length rat io
Reference standards Upper endoscopy







Implications in a hypo-
thetical cohort of 1000
people
Post- test probability Quality and comments
Any varices
Cut-of f value: 909 (n/
mm3)/ mm
Sensit ivity 0.93 (0.93 to
0.87)






2637 part icipants (17) 58%
(38% to 75%)
With a prevalence of
58%, 580 out of 1000
people will have varices
of any size. Of these
580 people, 41 (7%






The remaining 420 peo-




• If test posit ive:
89%
• If test negat ive:
10%







































































































































































67 people (16% of 420)
will receive false diag-
nosis of varices and




value: around 909 (n/
mm3)/ mm (range 897
to 921 (n/ mm3)/ mm)
Sensit ivity 0.85 (0.72 to
0.93)






642 part icipants (7) 60%
(18% to 70%)
With a prevalence of
60%, 600 out of 1000
people will have varices
at high risk of bleeding.
Of these 2600 people,
90 (15% of 600) people
with high-risk varices
will receive misdiagno-
sis and will not receive
ef fect ive prophylaxis
The remaining 400 peo-
ple will not have high-
risk varices. 136 peo-
ple (34% of 400) will
receive false diagnosis
of high-risk varices and





• If test posit ive:
79%
• If test negat ive:
25%
Most studies are at high
risk of bias
Median prevalence of









































































































































































What is the diagnostic accuracy of platelet count?
Review question What is the diagnostic accuracy of platelet count for the diagnosis of oesophageal varices in paediatric people with liver disease or portal vein
thrombosis?
Population Children with diagnosis of chronic liver disease or portal vein thrombosis. Age < 18 years
Settings Outpat ients and inpat ients in secondary/ tert iary care sett ing
Study design Prospect ive and retrospect ive cross-sect ional studies. No case-control studies were found
Index tests Platelet count
Reference standards Upper endoscopy







Implications in a hypo-
thetical cohort of 1000
people
Post- test probability Quality and comments
Any varices
Cut-of f value: around
120,000 / mm3 (range
115,000 to 119,000/
mm3)
Sensit ivity 0.71 (0.60 to
0.80)






277 part icipants (4) 58%
(48% to 69%)
With a prevalence of
58%, 580 out of
1000 children will have
varices of any size. Of
these 580 children, 168
(29% of 580) children









• If test posit ive:
85%
• If test negat ive:
32.5%







































































































































































dren will have no
varices. 71 children
(17% of 420) will re-
ceive false diagnosis









































































































































































What is the diagnostic accuracy of platelet count- to-spleen length ratio?
Review question What is the diagnostic accuracy of platelet count- to-spleen length ratio for the diagnosis of oesophageal varices in paediatric people with liver
disease or portal vein thrombosis?
Population Children with diagnosis of chronic liver disease or portal vein thrombosis. Age < 18 years
Settings Outpat ients and inpat ients in secondary/ tert iary care sett ing
Study design Prospect ive and retrospect ive cross-sect ional studies. No case-control studies were found
Index tests Platelet count-to-spleen length rat io
Reference standards Upper endoscopy




Prevalences Implications in a hypo-
thetical cohort of 1000
people
Post- test probability Quality and comments
Any varices
Cut-of f value: around
1000 (n/ mm3)/ mm
Sensit ivity 0.74 (0.65 to
0.81)
Specif icity 0.64 (0.36 to
0.85)
LR+ 2.0 (1.0 to 4.0)
LR- 0.41 (0.27 to 0.61)
197 part icipants
(2)
72% and 73% With a prevalence of 50%,
500 out of 1000 children
will have varices of any
size. Of these 500 chil-
dren, 130 (26% of 500)
children with varices will
receive misdiagnosis and
will not receive appropri-
ate prophylaxis or follow-
up
The remaining 500 chil-
dren will have no varices.
180 children (36% of 500)
Assuming a pretest proba-
bility of 50%
Post-test probabilit ies:
• If test posit ive: 67%
• If test negat ive: 29%
Limited evidence. Only 2
studies were found.
These 2 studies were at






































































































































































will receive false diagno-
sis of varices and will un-








































































































































































D I S C U S S I O N
Summary of main results
We included 71 studies, 67 of which enrolled only adults and four
only children. We considered and analysed these four paediatric
studies separately because they enrolled only paediatric patients
with a different spectrum of the liver disease.
For adults, all included studies were undertaken in a secondary/
tertiary care setting, and studies reported a wide range of preva-
lences of oesophageal varices - both varices of any size and high-
risk varices. We considered all but one of the included studies to
be at high risk of bias. We had major concerns about the predefi-
nition of the cut-off value for the three index tests: Most included
studies derived a posteriori the best cut-off values, overestimating
accuracy. Only 10 studies assessed a predefined cut-off value of
platelet count, and only 16 were designed to validate the 909 (n/
mm3)/mm cut-off value for platelet count-to-spleen length ratio.
Platelet count-to-spleen length ratio seems the most accurate test -
more accurate than simple platelet count or spleen lengthmeasure-
ment for the diagnosis of varices of any size or high-risk varices.
As expected, combining two measurements in a ratio improved
accuracy: For portal hypertension, platelet count (numerator) de-
creases and spleen length (denominator) increases.
Estimates of sensitivity and specificity obtained by the bivariate
model are reported in the ’Summary of findings’ tables (Summary
of findings 1; Summary of findings 2; Summary of findings 3;
Summary of findings 4; Summary of findings 5).
For the 17 studies assessing ratio of platelet count to spleen length
using the cut-off value of 909 (n/mm3)/mm for the diagnosis of
varices of any size, sensitivity was 0.93 and specificity 0.84 (Table
2), whereas for high-risk varices, accuracy was lower: sensitivity
0.85 and specificity 0.66. We found some heterogeneity of results
that was not due to a threshold effect, as the same cut-off value
was used. Moreover, we found no effect of other explored factors:
aetiology, severity of liver disease (Child class), and prevalence of
the target disease.
For platelet count, accuracy estimates varied according to the dif-
ferent cut-off values used in the included studies (Table 2). A low
platelet count is associated with portal hypertension, and hence
with oesophageal varices. As expected, with use of 120,000/mm
3 instead of 100,000/mm3 as a cut-off value, sensitivity increased
and specificity decreased. In contrast, when the highest value of
150,000/mm3 was used, sensitivity decreased and specificity in-
creased unexpectedly. Furthermore, we found an effect of aetiology
of liver disease (chronic hepatitis C vs other or mixed aetiologies),
but other factors such as prevalence of varices or severity of liver
disease (proportion of Child A) showed no effect on accuracy.
A large spleen is associated with portal hypertension, and a higher
cut-off value (150 mm vs 110 mm) showed, as expected, lower
sensitivity and higher specificity (Table 2). We found no effect of
the other explored sources of heterogeneity.
Platelet count-to-spleen length ratio is a simple and inexpensive
test that is available for all patients with cirrhosis at the moment
of diagnosis and at any follow-up control. Its accuracy allows the
clinician to identify a patient with low risk of oesophageal varices.
With assumption of prevalence of 58%, which is the median of
the included studies and is close to the expected value of 50% in
compensated cirrhosis (Garcia-Tsao 2007), only 10% will be false
negative (Summary of findings 3). These patients, in the case of
varices of any size, would miss an adequate follow-up, and, in the
case of high risk of bleeding varices, would miss an effective pro-
phylaxis. As the proportion of high-risk varices at the moment of
first detection in compensated cirrhosis is lower than 30%, only
about 3% of these patients should actually lose the opportunity
of receiving effective treatment. When a non-invasive test is used
for screening oesophageal varices, a recent consensus conference
defined as acceptable and safe a proportion of less than 5% of false
negative results in the case of high-risk varices requiring prophy-
laxis (de Franchis 2015; Abraldes 2016). On the other hand, as
shown in Summary of findings 3, in the case of prevalence of high-
risk varices of 60%, platelet count-to-spleen length ratio seems
inadequate for ruling out or ruling in the presence of high-risk
varices, as 15% of patients with high-risk varices would be missed
and 21% of patients with a positive test result would be false pos-
itive and consequently overtreated. Finally, if this test is used as a
triage test, 394 out of 1000 adults could avoid upper endoscopy,
and only 10% would be false negatives for the diagnosis of varices
of any size.
Assessment of any new non-invasive test should take into account
that platelet count-to-spleen length ratio is an accurate and widely
available test not requiring additional costs at the moment of di-
agnosis of cirrhosis. It can also be combined with other tests such
as liver stiffness or spleen stiffness measurement by transient elas-
tography, or other techniques. Liver stiffness is widely used and, at
least in cases of chronic hepatitis C, can replace histology for the
diagnosis of cirrhosis, with high values predicting the presence of
portal hypertension. Its accuracy can be further increased by com-
bining liver stiffness measurements with platelet count (Abraldes
2016; de Franchis 2015), or hypothetically with platelet count-
to-spleen length ratio.
Finally, from the four paediatric studies that considered platelet
count (including 294 paediatric participants with different types
of liver disease and/or portal vein thrombosis), we obtained esti-
mates of sensitivity 0.71 and specificity of 0.83. These four stud-
ies used similar, not predefined, cut-off values (range 115,000 to
119,000/mm3). Given that spleen length in paediatric patients
changes with age, we included and analysed for the index tests of
spleen length and platelet count-to-spleen length ratio only stud-
ies that expressed spleen size in a way that corrects for expected
changes for age (z-score). We found two studies with 197 paedi-
atric participants that assessed the platelet count-to-spleen length
z-score ratio, using cut-off values of 24 and 25, and we obtained
estimates of sensitivity (0.74) and specificity (0.64). We found no
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studies assessing the accuracy of spleen length z-score.
Strengths and weaknesses of the review
We aimed to assess the accuracy of three index tests for the diagno-
sis of oesophageal varices and included 71 studies that were con-
ducted in many countries, showed widespread implementation
globally of the index tests, and confirmed the clinical relevance of
this review question. We identified four studies through manual
searching of non-indexed journals and are confident that we have
included most, if not all, of the includable published studies. We
also assessed the accuracy of the index tests to detect varices that
are at high risk of bleeding, which provide the main clinical reason
for screening cirrhotic patients with endoscopy. Moreover, the in-
cluded studies allowed comparison of the accuracies of the three
index tests.
An overall quality assessment of the studies showed several com-
mon methodological weaknesses, and we considered only one
study to have low risk of bias. Most studies derived “a posteriori”
the optimal cut-off value with consequent overestimation of accu-
racy. Furthermore, in many instances, study reporting was incom-
plete, and investigators provided no information about consecu-
tive enrolment and blinding of the reference standard. Prevalence
of the target disease varied widely, suggesting different inclusion
criteria, with participants enrolled not only at the time of diag-
nosis of cirrhosis, but also during follow-up; and non-consecutive
enrolment, with retrospective selection based on available data.
Anyway, the median prevalence of varices of any size was close to
the expected value of around 50%. In contrast, prevalence of high-
risk varices was much higher than expected, suggesting that the
index test was used not at the time of diagnosis of cirrhosis, but
later, to monitor the development of complications.
Despite the large numbers of included studies and participants,
estimates of accuracy were imprecise, and results of included stud-
ies were not consistent. This heterogeneity could be explained
only in part by the use of different cut-off values. Sources of this
heterogeneity remained unexplained, even after inspection of the
most likely explanatory variables, such as different severity and
aetiology of liver disease and different prevalence of oesophageal
varices. However, for the index test platelet count-to-spleen length
ratio, we found 17 studies (with 2637 participants) that used the
same cut-off value: one derivation study and 16 validation studies.
Through meta-analysis of the results of these studies, we obtained
consistent estimates of sensitivity and specificity, which could sup-
port the use of platelet count-to-spleen length ratio with this cut-
off to rule out the presence of varices in adults with cirrhosis.
Available data prevent proper comparison of accuracy through di-
rect comparison of the three index tests, each with the same prede-
fined cut-off value. The included studies mainly allowed indirect
comparisons, and in the case of direct comparisons, different cut-
off values were used across studies, preventing clear interpretation
of results.
Another possible limitation of the review is that the reference stan-
dard for diagnosis and staging of oesophageal varices is not perfect.
In fact, interobserver agreement in interpretation of oesophago-
gastro-duodenoscopy findings is unfortunately well below that de-
sired for an ideal reference standard (Cales 1989; Bendtsen 1990;
Winkfield 2003). This poor reproducibility of the reference stan-
dard could impair the accuracy estimation of the index tests. Fur-
thermore, included studies assessed the accuracy of index tests in
diagnosing varices of any size or large oesophageal varices or both,
but they did not directly assess bleeding risk by measuring actual
bleeding outcomes. Thus, these studies could not answer directly
the question of whether these index tests can predict bleeding or
can properly indicate which people might benefit from primary
prophylactic treatment.
We found two reviews on the same topic, both assessing the accu-
racy of platelet count-to-spleen length ratio (Chawla 2012; Ying
2012). One of these reviews considered only studies assessing the
accuracy of the ratio with the predefined cut-off value of 909 (n/
mm3)/mm and included only eight studies (Chawla 2012). We
found and included nine additional studies that validated this cut-
off. The other review (Ying 2012) included 20 studies assessing the
accuracy of the ratio on the basis of all cut-off values. In our review,
we found 18 additional studies. Furthermore, in both reviews, the
statistical approach was not the most appropriate, as neither bi-
variate nor hierarchical summary receiver operating characteristic
(HSROC) models were used.
Applicability of findings to the review question
The accuracy of platelet count, spleen length, and platelet count-
to-spleen length ratio in detecting the presence of oesophageal
varices has been, with the limitations noted above, addressed in a
tertiary care setting and in adult patients with suspected cirrhosis
mainly due to chronic viral hepatitis or alcoholic liver disease. It
is uncertain how applicable these results may be to other specific
patient groups, such as those with cholestatic disease or portal
vein thrombosis, children with liver disease, or patients in other
settings.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Although current guidelines recommend use of oesophago-gastro-
duodenoscopy to screen for varices in all adults with suspected
cirrhosis, poor uptake of this recommendation has occurred be-
cause oesophago-gastro-duodenoscopy is invasive and unpleasant,
and has a low diagnostic yield when applied to all adults with cir-
rhosis (Garcia-Tsao 2007; Garcia-Tsao 2008; de Franchis 2010).
Therefore, a pressing need exists for a non-invasive test that en-
ables oesophago-gastro-duodenoscopy to be avoided or applied to
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a higher-risk patient group (de Franchis 2015; Garcia-Tsao 2017).
This review shows that a simple test such as platelet count-to-
spleen length ratio could be used to stratify the risk of oesophageal
varices, particularly as a triage test before endoscopy to rule out
people without varices. In fact, in the case of a ratio greater than
909 (n/mm3)/mm, only 7% of patients with varices of any size
would be missed and would not receive appropriate prophylaxis or
follow-up. If prevalence of varices of 58% is assumed, the negative
predictive value of the test is 90% and about 40% of esophago-
gastro-duodenoscopy examinations for screening people with cir-
rhosis would be spared. However, most studies were at high risk
of bias and estimates of sensitivity and specificity were imprecise,
limiting the strength of this conclusion. Furthermore, prevalence
of the target condition widely varied, suggesting differences in
study design or participant selection.
For detection of high risk of bleeding varices, included studies re-
ported prevalence of 60%, which is higher than expected, espe-
cially if the test is used at the time of diagnosis of cirrhosis. In
this context, the test is not accurate enough to replace endoscopy,
with 15% of patients missing a correct diagnosis and the conse-
quent primary prophylaxis. In fact, a proportion of less than 5%
for missed diagnosis is regarded by experts as acceptable and safe
(de Franchis 2015; Abraldes 2016).
Implications for research
To better define the role of platelet count-to-spleen size ratio in
clinical practice, future studies should explore the following areas.
1. Diagnostic accuracy of these non-invasive tests when used
in specific subgroups of patients, such as patients with different
causes of portal hypertension, with different severity of liver
disease, or of different age groups (paediatric patients), or those
for whom different classification systems for varices are used.
2. Diagnostic accuracy of platelet count-to-spleen size ratio in
predicting variceal bleeding and real-world effectiveness and
cost-effectiveness of management strategies that employ platelet
count-to-spleen size ratio to identify patients for primary
prophylaxis of variceal bleeding, compared with the currently
recommended approach using oesophago-gastro-duodenoscopy
alone.
3. Assessment of new non-invasive tests for detection of
oesophageal varices should also include comparison with platelet
count-to-spleen size ratio.
When diagnostic strategies have been refined, these ought to be
assessed for benefits and harms in randomised clinical trials (Colli
2014a).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Abd-Elsalam 2016b
Study characteristics Study characteristics
Patient sampling Prospective cross-sectional
Patient characteristics and set-
ting
110 adult patients with cirrhosis due to hepatitis C virus. Child A 49.1%. Setting: tertiary referral
centre in Egypt
Index tests Platelet count
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
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Abd-Elsalam 2016b (Continued)
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional
Patient characteristics and set-
ting
175 consecutive adult patients with cirrhosis due to hepatitis C virus. Child A only 26%.Histological
diagnosis of cirrhosis in 26% of patients. Setting: tertiary referral centre in Egypt
Index tests Platelet count-to-spleen length ratio
Target condition and reference
standard(s)
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Abu 2011 (Continued)
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN 2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Abu 2011 (Continued)
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional
Patient characteristics and set-
ting
103 paediatric patients (98 with chronic liver disease, 5 with extrahepatic portal vein obstruction).
55% Child A. Setting: tertiary referral centre in Brazil
Index tests Platelet count, platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
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Adami 2013 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN 2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Agha 2009
Study characteristics Study characteristics
Patient sampling Prospective cross-sectional.
Patient characteristics and set-
ting
316 consecutive adult patients with hepatitis C-related liver cirrhosis. Child A: 25.8%. Setting:
tertiary referral centre in Pakistan
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)
Any oesophageal varices. Upper endoscopy




Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN 2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
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Agha 2009 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional
Patient characteristics and set-
ting
43 consecutive adult patients with evidence of schistosomal infection (based on seropositivity for
Schistosoma mansonii) and periportal hepatic fibrosis confirmed on abdominal ultrasound. Setting:
referral tertiary centre in Kingdom of Saudi Arabia
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)
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Agha 2011 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN 2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
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Agha 2011 (Continued)





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional
Patient characteristics and set-
ting
53 paediatric patients. 35 with chronic liver disease and 18 with extrahepatic portal obstruction.
Child A: 82.4%. Setting: tertiary referral centre in Brazil
Index tests Platelet count
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Alcantara 2012 (Continued)




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional
Patient characteristics and set-
ting
95 adult patients with HCV cirrhosis. Child A: 30%. Setting: tertiary referral centre in Pakistan
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)
Any oesophageal varices. Upper endoscopy
Flow and timing
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Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN 2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
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Amin 2012 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional
Patient characteristics and set-
ting
797 adult patients. Setting: tertiary referral centre in Morocco
Index tests Platelet count
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Aqodad 2011 (Continued)
DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional
Patient characteristics and set-
ting
150 consecutive adult patients. Child A: 64.7%. Setting: tertiary referral centre in India
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Baig 2008 (Continued)
Index tests Platelet count; spleen diameter; platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN 2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Baig 2008 (Continued)




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
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Study characteristics Study characteristics
Patient sampling Prospective cross-sectional
Patient characteristics and set-
ting
50 adult patients with cirrhosis. Child A: 10%. Setting: tertiary referral centre in Iran
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN 2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
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Barikbin 2010 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Cross-sectional
Patient characteristics and set-
ting
101 adult patients. Accuracy data reported only for 36 Child A patients. Child A: 100%. Setting:
tertiary referral centre in Italy
Index tests Platelet count
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
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Burton 2007a (Continued)
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Study characteristics Study characteristics
Patient sampling Cross-sectional
Patient characteristics and set-
ting
252 consecutive adult patients. Accuracy data reported only for 138 Child A patients. Child A:
100%. Setting: tertiary referral centre in USA
Index tests Platelet count
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
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Burton 2007b (Continued)
Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Cross-sectional
Patient characteristics and set-
ting
152 consecutive adult patients. Accuracy data reported only for 74 Child A patients. Child A: 100%.
Setting: tertiary referral centre in USA
Index tests Platelet count
Target condition and reference
standard(s)
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Burton 2007c (Continued)
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Burton 2007c (Continued)
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Cross-sectional
Patient characteristics and set-
ting
152 consecutive adult patients. Accuracy data reported only for 78 Child B/CA patients. Child A:
0%. Setting: tertiary referral centre in USA
Index tests Platelet count
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
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Burton 2007d (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional
Patient characteristics and set-
ting
104 consecutive adult patients. Child A: 100%. Setting: tertiary referral centre in Italy
Index tests Platelet count-to-spleen diameter ratio
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Camma 2009 (Continued)
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN 2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
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Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Cross-sectional
Patient characteristics and set-
ting
70 consecutive adult patients with histologically proven cirrhosis HCV related. Child A: 100%.
Setting: tertiary referral centrer in France. Multi-centre
Index tests Platelet count
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Castera 2009 (Continued)




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
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Study characteristics Study characteristics
Patient sampling Prospective cross-sectional
Patient characteristics and set-
ting
229 consecutive adult patients. Child A: 18.3%. Setting: tertiary referral centre in India
Index tests Platelet count, platelet count-to-spleen diameter ratio, spleen diameter
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN 2: Index
ratio
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Cherian 2011 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
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Chiodi 2014
Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional
Patient characteristics and set-
ting
125 adult patients with cirrhosis. Child A: not reported. Tertiary referring centres in Uruguay
Index tests Platelet count, platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
No




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN 2: Index
ratio
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Chiodi 2014 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
No




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional
Patient characteristics and set-
ting
33 paediatric patients who had undergone Kasai portoenterostomy. Child A: 77%. Tertiary referring
centre in Italy
Index tests Platelet count, platelet count-to-spleen length ratio, spleen length
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Colecchia 2011 (Continued)
Target condition and reference
standard(s)
Presence of any oesophageal varices. Upper endoscopy
Flow and timing
Comparative
Notes Individual patient data available - paediatric
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
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Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
113 consecutive adult patients. Child A: 68%. Setting: tertiary referral centre in Italy
Index tests Platelet count, platelet count-to-spleen diameter ratio, spleen diameter
Target condition and reference
standard(s)
Presence of any oesophageal varices. Upper endoscopy
Flow and timing 13 patients excluded from the analysis
Comparative
Notes Individual patient data available
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Colecchia 2012 (Continued)




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
160 adult patients. Child A: 57.6%. Setting: tertiary referral centre in Brazil
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
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De Mattos 2010 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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De Mattos 2010 (Continued)
Low
Ding 2016
Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional
Patient characteristics and set-
ting
271 adult patients with cirrhosis. Child A: 100%. Tertiary referral centres in Australia
Index tests Platelet count
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
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Low Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Cross-sectional study
Patient characteristics and set-
ting
118 adult patients. Child A: not reported. Setting: tertiary referral centre in Australia
Index tests Spleen size
Target condition and reference
standard(s)
Presence of any oesophageal varices. Upper endoscopy
Flow and timing Only 86/118 patients underwent endoscopy
Comparative
Notes
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Ditchfield 1992 (Continued)
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Ditchfield 1992 (Continued)
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
175 adult patients. Child A: 26.3. Setting: tertiary referral centre in Egypt
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
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El Makarem 2011 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Cross-sectional study
Patient characteristics and set-
ting
80 adult patients
Index tests Platelet count-to-spleen diameter ratio
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El Ray 2015 (Continued)
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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El Ray 2015 (Continued)
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
100 adult patients. Child A: 20%. Etiology: all patients with HCV. Setting: tertiary referral centre
in Egitto
Index tests Platelet count, platelet count-to-spleen diameter ratio, spleen diameter
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
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Esmat 2012 (Continued)




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Esmat 2012 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
108 paediatric patients. Child A: 78%. Setting: tertiary referral centres - multi-centre
Index tests Platelet count
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
112Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic
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Gana 2011 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
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Gana 2011 (Continued)
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
235 adult patients. Child A: not reported. Setting: tertiary referral centre in Italy
Index tests Platelet count
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
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Gentile 2009 (Continued)
Low Low
DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
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Giannini 2003a (Continued)
Patient characteristics and set-
ting
145 adult patients. Child A: 37%. Setting: tertiary referral centre in Italy
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Giannini 2003a (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
121 adult patients. Child A: 41%. Setting: tertiary referral centre in Italy
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
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Giannini 2003b (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
118Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic
liver disease or portal vein thrombosis (Review)




Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
106 adult patients. Child A: 59%. Setting: tertiary referral centre in Italy
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)
Presence of any oesophageal varices. Upper endoscopy
Flow and timing 31 patients lost to follow-up, 6 deaths, 1 OLT
Comparative
Notes Study included only patients with previous (24 months) negative endoscopy
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Giannini 2005 (Continued)




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
218 adult patients. Child A: 51%. Setting: tertiary referral centres in Europe and USA
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)
Presence of any oesophageal varices. Upper endoscopy
Flow and timing
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Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
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Giannini 2006 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
91 adult patients. Child A: 19%. Setting: tertiary referral centre in Mexico
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
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Gonzalez-Ojeda 2014 (Continued)
DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
117 adult patients with alcoholic cirrhosis. Patients with previous variceal bleeding have been
included. Child A: 14.6%. Setting: tertiary referral centre in Croatia
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Grgurevic 2014 (Continued)
Index tests Spleen diameter and platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Grgurevic 2014 (Continued)




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
52 adult patients. Child A: 51%. Setting: tertiary referral centres in Korea
Index tests Spleen diameter
Target condition and reference
standard(s)
Presence of any oesophageal varices. Upper endoscopy
Flow and timing
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Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
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Jeon 2006 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
38 adult patients. Child A: 55%. Setting: tertiary referral centre in Greece
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
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Karatzas 2016 (Continued)
DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
150 adult patients. Child A: not reported. Setting: tertiary referral centre in Philippines
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Legasto 2006 (Continued)
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Legasto 2006 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
326 adult patients. Child A: not reported. Setting: tertiary referral centre in China
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
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Lei 2007 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
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Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
113 adult patients with PBC. Setting: tertiary referral centre in USA
Index tests Platelet count
Target condition and reference
standard(s)
Presence of any oesophageal varices. Upper endoscopy




Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
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Levy 2007a (Continued)
High Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
92 adult patients with PBC. Setting: tertiary referral centre in USA
Index tests Platelet count
Target condition and reference
standard(s)
Presence of any oesophageal varices. Upper endoscopy
Flow and timing Only 36/92 underwent endoscopy
Comparative
Notes
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Levy 2007b (Continued)
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Levy 2007b (Continued)
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
192 consecutive adult patients. Child A: 43.5%. Setting: tertiary referral centre in USA
Index tests Platelet count, spleen diameter
Target condition and reference
standard(s)
Presence of high-risk oesophageal varices. Upper endoscopy




Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
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Madhotra 2002 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes




136Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic
liver disease or portal vein thrombosis (Review)
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Mahassadi 2012a
Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
111 consecutive adult patients (training set). Child A: 22.5%. Setting: tertiary referral centres in
Ivory Coast
Index tests Platelet count, spleen diameter, and platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
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Mahassadi 2012a (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
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Mahassadi 2012b
Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
91 consecutive adult patients (validation set). Child A: 19.8%. Setting: tertiary referral centre in
Ivory Coast
Index tests Platelet count, spleen diameter, and platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
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Mahassadi 2012b (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
47 adult patients. Child A: not reported. Setting: tertiary referral centre in Peru
Index tests Platelet count-to-spleen diameter ratio
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Mosqueira 2011 (Continued)
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
158 consecutive adult patients. Child A: 64%. Setting: tertiary referral centre in Italy
Index tests Platelet count, platelet count-to-spleen diameter ratio, spleen diameter
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Parrino 2008 (Continued)




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
116 consecutive adult patients. Child A: 50%. Setting: tertiary referral centre in France
Index tests Platelet count
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
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Pilette 1999 (Continued)
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Prihatini 2005
Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
47 consecutive adult patients. Child A: 59.6%. Setting: tertiary referral centre in Indonesia
Index tests Platelet count
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
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Prihatini 2005 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
250 consecutive adult patients. Child A: 91.6%. Setting: tertiary referral centre in Italy
Index tests Spleen diameter
Target condition and reference
standard(s)
Presence of any oesophageal varices. Upper endoscopy
Flow and timing Upper gastrointestinal endoscopy performedwithin 6months of liver biopsy. Time interval between
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Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
148Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic
liver disease or portal vein thrombosis (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Primignani 2002 (Continued)





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
1016 consecutive adult patients. Child A: 100%. Setting: tertiary referral centres in USA
Index tests Platelet count
Target condition and reference
standard(s)
Presence of any and high-risk oesophageal varices. Upper endoscopy
Flow and timing
Comparative
Notes This report included all randomised patients at all clinical centres participating in the HALT-C trial
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Sanyal 2006 (Continued)




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
106 consecutive adult patients. Child A: not reported. Setting: tertiary referral centre in India
Index tests Platelet count, platelet count-to-spleen diameter ratio, spleen diameter
Target condition and reference
standard(s)
Presence of any and high-risk oesophageal varices. Upper endoscopy
Flow and timing
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Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
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Sarangapani 2010 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
137 consecutive adult patients. Child A: 48%. Setting: tertiary referral centre in USA
Index tests Platelet count, platelet count-to-spleen diameter ratio
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Schwarzenberger 2010 (Continued)
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
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Unclear Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
510 non-consecutive adult patients. Child A: 79%. Setting: 5 tertiary referral centres in Italy and
France
Index tests Platelet count
Target condition and reference
standard(s)
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Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Sebastiani 2010 (Continued)
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
93 adult patients with HCV. Child A: not reported. Setting: tertiary referral centre in UK
Index tests Platetet count, spleen diameter, and platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
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Sen 2008a (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
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Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
77 adult patients with alcoholic cirrhosis. Child A: not reported. Setting: tertiary referral centre in
UK
Index tests Platetet count, spleen diameter, and platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
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Sen 2008b (Continued)
DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
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Sen 2008b (Continued)
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
200 consecutive adult patients. Child A: 79%. Setting: not reported
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)
Presence of any oesophageal varices. Upper endoscopy




Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
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Sharma 2013 (Continued)
Low Low
DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Sharma 2014
Study characteristics Study characteristics
Patient sampling Cross-sectional study
Patient characteristics and set-
ting
100 adult patients. Child A: 18%. Setting: tertiary referral centre in India
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
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Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
100 adult patients. Child A: not reported. Setting: tertiary referral centre in Egypt
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
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DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
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Sheta 2016 (Continued)





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
137 adult patients. Child A: 64.9%. Setting: tertiary referral centre in Romania
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
Unclear
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Stefanescu 2011 (Continued)
dard?




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
300 adult patients. Child A: 71%. Setting: not reported
Index tests Platelet count
Target condition and reference
standard(s)
Presence of any and high-risk oesophageal varices. Upper endoscopy
Flow and timing
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Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
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Tafarel 2011 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
340 consecutive adult patients. Child A: 67%. Setting: tertiary referral centres in Japan
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)
Presence of any and high-risk oesophageal varices. Upper endoscopy




Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Takuma 2013 (Continued)
DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
153 consecutive adult patients. Child A: 42%. Setting: tertiary referral centre in Italy
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Tarantino 2009 (Continued)
Index tests Spleen diameter
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
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of the results of the index tests?
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
111 adult patients. Child A: 41%. Setting: tertiary referral centre in Pakistan
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
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Wadhva 2012 (Continued)
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Wang CC 2015
Study characteristics Study characteristics
Patient sampling Cross-sectional study
Patient characteristics and set-
ting
42 adult patients. Child A: not reported. Setting: tertiary referral centre in Taiwan
Index tests Spleen diameter
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Spleen length DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
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Wang CC 2015 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
46 adult patients. Child A: not reported. Setting: tertiary referral centre in Taiwan
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
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Wang HM 2012 (Continued)
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Wang HM 2012 (Continued)





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
126 adult patients. Child A: 100%. Setting: tertiary referral centre in Taiwan
Index tests Platelet count
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Wang JH 2012 (Continued)




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
236 adult patients. Child A: not reported. Setting: tertiary referral centre in China
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)
Presence of any oesophageal varices. Upper endoscopy
Flow and timing
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Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
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Xu 2016a (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Prospective cross-sectional study
Patient characteristics and set-
ting
215 adult patients. Child A: not reported. Setting: tertiary referral centre in Pakistan
Index tests Platelet count-to-spleen diameter ratio
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




179Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic
liver disease or portal vein thrombosis (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Zafar 2014 (Continued)
DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
300 adult patients. Child A: 22%. Setting: tertiary referral centre in USA
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Zaman 2001 (Continued)
Index tests Platelet count
Target condition and reference
standard(s)
Presence of any and high-risk oesophageal varices. Upper endoscopy
Flow and timing
Comparative
Notes Study authors wrote, “This was an unmatched case-control study, with cases and controls selected
from patients undergoing liver transplantation evaluation at the OHSU/PVAMC Liver Transplan-
tation Program between January 1, 1995, and September 1, 1999”
This sentence might suggest a case-control design
However, careful reading of the paper reveals that it is clear that the study design is not case-control
but retrospective cross-sectional based on registry data
“This study presents the results from the entire cohort of liver transplantation patients undergoing
liver transplantation evaluation at the OHSU/PVAMC Liver Transplant Department between Jan-
uary 1, 1995, and September 1, 1999”
“629 cirrhotic patients underwent liver transplantation evaluation. Of these, 300 patients did not
have a history of variceal hemorrhage (the study group)”
.
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
No
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Zaman 2001 (Continued)
High Low
DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
183 adult patients. Child A: not applicable (only PSC participants). Setting: tertiary referral centre
in USA
Index tests Platelet count
Target condition and reference
standard(s)
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Zein 2004a (Continued)
Methodological quality Methodological
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Zein 2004a (Continued)
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
72 adult patients. Child A: not applicable (only PSC participants). Setting: tertiary referral centre
in USA
Index tests Platelet count
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count DOMAIN 2: Index
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Zein 2004b (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes





Study characteristics Study characteristics
Patient sampling Retrospective cross-sectional study
Patient characteristics and set-
ting
40 adult patients. Child A: not reported. Setting: tertiary referral centre in UK
Index tests Platelet count-to-spleen diameter ratio
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Zimbwa 2004 (Continued)
Target condition and reference
standard(s)





Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection DOMAIN 1: Patient
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test Platelet count to spleen length ratio DOMAIN2: Index
ratio
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard DOMAIN 3: Refer
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Zimbwa 2004 (Continued)
Unclear Low
DOMAIN 4: Flow and Timing DOMAIN 4: Flo
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes




HALT-C = hepatitis C antiviral long-term treatment against cirrhosis; HCV = hepatitis C virus; OLT = orthotopic liver transplantation;
PBC = primary biliary cholangitis; PSC = primary sclerosing cholangitis
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Albreedy 2015 No data for 2 × 2 table
Amarapurkar 1994 In only a minority of patients, spleen length was assessed by ultrasound
Barrera 2009 No data for 2 × 2 table
Chalasani 1999 Study provides data only for combination of splenomegaly and platelet count as predictors of oesophageal
varices. Individual 2 × 2 tables for platelet count or presence/absence of splenomegaly are not extractable
from manuscript
Cho 2015 No data for 2 × 2 table (Table S3 provides unreliable data)
El Guindi 2008 No data for 2 × 2 table
El-Sherif 2008 No data for 2 × 2 table. Published data not consistent. Study authors contacted by email. They did not
respond
Fagundes 2008 Not acceptable reference standard
Gana 2010 No data on index tests of interest
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(Continued)
Giannini 2007 Same data as Agha 2009 (n = 311 patients)
Hong 2009 Different index test (spleen width)
Koncoro 2014 No definition of the reference standard used
Lee 2009 No data for 2 × 2 table
Malik 2015 No data for 2 × 2 table
Nashaat 2010 No data for 2 × 2 table. Published data not consistent
Nazish 2011 No data for 2 × 2 table
Ng 1999 Study identified patients with oesophagogastric varices
Park 2015 No data for 2 × 2 table
Qamar 2008 No data for 2 × 2 table
Rockey 2016 Only patients wih acute upper gastrointestinal bleeding were included
Sebastiani 2008 Preliminary data (Sebastiani 2010)
Sethar 2006 No data for 2 × 2 table
Shah 2011 No data for 2 × 2 table
Sharma 2007 Platelet data for large oesophageal varices were not extractable from the text. Study proposes predictor function
model derived from multi-variate analysis as better model to predict large oesophageal varices
Takuma 2016 No data for 2 × 2 table
Tao 2008 No data for 2 × 2 table. Published data not consistent
Thayumanavan 2012 No data for 2 × 2 table
Thomopoulos 2003 No data for 2 × 2 table
Treeprasertsuk 2010 No data for 2 × 2 table
Valente No data for 2 × 2 table
Yu 2008 Different definition of the target condition (data reported only for severe vs moderate small and no varices)
Zaman 1999 Overlap with Zaman 2001
Zhang 2013 Reference standard different from endoscopy
188Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic
liver disease or portal vein thrombosis (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Zhang 2016 No data for 2 × 2 table. Published data not consistent (see Table 3: sensitivity and specificity not consistent
with positive and negative predictive values)
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D A T A
Presented below are all the data for all of the tests entered into the review.






1 Adults - platelet count - any
varices
25 5096
2 Adults - platelet count - any
varices - cut-off around
100,000
11 3506
3 Adults - platelet count - any
varices - cut-off around
120,000
7 815
4 Adults - platelet count - any
varices - cut-off around
150,000
10 2054
5 Adults - platelet/spleen ratio -
any varices
38 5235
6 Adults - platelet/spleen ratio -
any varices - cut-off 909
17 2637
7 Adults - spleen diameter - any
varices
13 1489
8 Adults - spleen diameter - any
varices - cut-off around 110
mm
5 594
9 Adults - spleen diameter - any
varices - cut-off around 150
mm
5 598
10 Adults - platelet count -
high-risk varices
21 4266
11 Adults - platelet count -
high-risk varices - cut-off
around 90,000
11 3084
12 Adults - platelet count -
high-risk varices - cut-off
around 150,000
7 1671
13 Adults - platelet/spleen ratio -
high-risk varices
10 930
14 Adults - platelet/spleen ratio
- high-risk varices - cut-off
around 909
7 642
15 Adults - spleen diameter -
high-risk varices
6 883
16 Paediatrics - platelet count -
any varices
4 277
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17 Paediatrics - platelet/spleen
ratio z-score - any varices
2 197
Test 1. Adults - platelet count - any varices.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 1 Adults - platelet count - any varices
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abd-Elsalam 2016b 66 11 21 12 0.76 [ 0.65, 0.84 ] 0.52 [ 0.31, 0.73 ]
Aqodad 2011 371 38 330 58 0.53 [ 0.49, 0.57 ] 0.60 [ 0.50, 0.70 ]
Baig 2008 85 11 21 33 0.80 [ 0.71, 0.87 ] 0.75 [ 0.60, 0.87 ]
Burton 2007d 27 8 29 14 0.48 [ 0.35, 0.62 ] 0.64 [ 0.41, 0.83 ]
Castera 2009 14 11 11 34 0.56 [ 0.35, 0.76 ] 0.76 [ 0.60, 0.87 ]
Chiodi 2014 55 14 24 32 0.70 [ 0.58, 0.79 ] 0.70 [ 0.54, 0.82 ]
Colecchia 2012 26 4 27 43 0.49 [ 0.35, 0.63 ] 0.91 [ 0.80, 0.98 ]
Esmat 2012 69 3 13 15 0.84 [ 0.74, 0.91 ] 0.83 [ 0.59, 0.96 ]
Gentile 2009 50 53 10 122 0.83 [ 0.71, 0.92 ] 0.70 [ 0.62, 0.76 ]
Levy 2007a 23 8 8 37 0.74 [ 0.55, 0.88 ] 0.82 [ 0.68, 0.92 ]
Levy 2007b 10 1 7 18 0.59 [ 0.33, 0.82 ] 0.95 [ 0.74, 1.00 ]
Mahassadi 2012a 68 8 17 18 0.80 [ 0.70, 0.88 ] 0.69 [ 0.48, 0.86 ]
Mahassadi 2012b 41 3 31 16 0.57 [ 0.45, 0.69 ] 0.84 [ 0.60, 0.97 ]
Parrino 2008 71 1 46 40 0.61 [ 0.51, 0.70 ] 0.98 [ 0.87, 1.00 ]
Prihatini 2005 33 6 3 5 0.92 [ 0.78, 0.98 ] 0.45 [ 0.17, 0.77 ]
Sanyal 2006 97 90 163 666 0.37 [ 0.31, 0.43 ] 0.88 [ 0.86, 0.90 ]
Schwarzenberger 2010 59 37 17 24 0.78 [ 0.67, 0.86 ] 0.39 [ 0.27, 0.53 ]
Sebastiani 2010 174 27 116 193 0.60 [ 0.54, 0.66 ] 0.88 [ 0.83, 0.92 ]
Sen 2008a 20 26 6 41 0.77 [ 0.56, 0.91 ] 0.61 [ 0.49, 0.73 ]
Sen 2008b 27 18 8 24 0.77 [ 0.60, 0.90 ] 0.57 [ 0.41, 0.72 ]
Tafarel 2011 109 46 62 83 0.64 [ 0.56, 0.71 ] 0.64 [ 0.55, 0.73 ]
Wang JH 2012 32 22 16 56 0.67 [ 0.52, 0.80 ] 0.72 [ 0.60, 0.81 ]
Zaman 2001 121 37 82 60 0.60 [ 0.53, 0.66 ] 0.62 [ 0.51, 0.72 ]
Zein 2004a 29 14 18 122 0.62 [ 0.46, 0.75 ] 0.90 [ 0.83, 0.94 ]
Zein 2004b 16 6 10 38 0.62 [ 0.41, 0.80 ] 0.86 [ 0.73, 0.95 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 2. Adults - platelet count - any varices - cut-off around 100,000.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 2 Adults - platelet count - any varices - cut-off around 100,000
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abd-Elsalam 2016b 40 6 47 17 0.46 [ 0.35, 0.57 ] 0.74 [ 0.52, 0.90 ]
Aqodad 2011 371 38 330 58 0.53 [ 0.49, 0.57 ] 0.60 [ 0.50, 0.70 ]
Burton 2007d 27 8 29 14 0.48 [ 0.35, 0.62 ] 0.64 [ 0.41, 0.83 ]
Colecchia 2012 26 4 27 43 0.49 [ 0.35, 0.63 ] 0.91 [ 0.80, 0.98 ]
Mahassadi 2012a 68 8 17 18 0.80 [ 0.70, 0.88 ] 0.69 [ 0.48, 0.86 ]
Mahassadi 2012b 41 3 31 16 0.57 [ 0.45, 0.69 ] 0.84 [ 0.60, 0.97 ]
Sanyal 2006 97 90 163 666 0.37 [ 0.31, 0.43 ] 0.88 [ 0.86, 0.90 ]
Sebastiani 2010 174 27 116 193 0.60 [ 0.54, 0.66 ] 0.88 [ 0.83, 0.92 ]
Sen 2008a 20 26 6 41 0.77 [ 0.56, 0.91 ] 0.61 [ 0.49, 0.73 ]
Tafarel 2011 109 46 62 83 0.64 [ 0.56, 0.71 ] 0.64 [ 0.55, 0.73 ]
Zaman 2001 121 37 82 60 0.60 [ 0.53, 0.66 ] 0.62 [ 0.51, 0.72 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 3. Adults - platelet count - any varices - cut-off around 120,000.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 3 Adults - platelet count - any varices - cut-off around 120,000
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Baig 2008 85 11 21 33 0.80 [ 0.71, 0.87 ] 0.75 [ 0.60, 0.87 ]
Chiodi 2014 55 14 24 32 0.70 [ 0.58, 0.79 ] 0.70 [ 0.54, 0.82 ]
Colecchia 2012 41 9 12 38 0.77 [ 0.64, 0.88 ] 0.81 [ 0.67, 0.91 ]
Esmat 2012 69 3 13 15 0.84 [ 0.74, 0.91 ] 0.83 [ 0.59, 0.96 ]
Schwarzenberger 2010 59 37 17 24 0.78 [ 0.67, 0.86 ] 0.39 [ 0.27, 0.53 ]
Sen 2008b 27 18 8 24 0.77 [ 0.60, 0.90 ] 0.57 [ 0.41, 0.72 ]
Wang JH 2012 32 22 16 56 0.67 [ 0.52, 0.80 ] 0.72 [ 0.60, 0.81 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 4. Adults - platelet count - any varices - cut-off around 150,000.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 4 Adults - platelet count - any varices - cut-off around 150,000
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abd-Elsalam 2016b 66 11 21 12 0.76 [ 0.65, 0.84 ] 0.52 [ 0.31, 0.73 ]
Castera 2009 14 11 11 34 0.56 [ 0.35, 0.76 ] 0.76 [ 0.60, 0.87 ]
Colecchia 2012 49 17 4 30 0.92 [ 0.82, 0.98 ] 0.64 [ 0.49, 0.77 ]
Gentile 2009 50 53 10 122 0.83 [ 0.71, 0.92 ] 0.70 [ 0.62, 0.76 ]
Levy 2007a 23 8 8 37 0.74 [ 0.55, 0.88 ] 0.82 [ 0.68, 0.92 ]
Levy 2007b 10 1 7 18 0.59 [ 0.33, 0.82 ] 0.95 [ 0.74, 1.00 ]
Parrino 2008 71 1 46 40 0.61 [ 0.51, 0.70 ] 0.98 [ 0.87, 1.00 ]
Sanyal 2006 184 277 76 479 0.71 [ 0.65, 0.76 ] 0.63 [ 0.60, 0.67 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
(Continued . . . )
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Zein 2004a 29 14 18 122 0.62 [ 0.46, 0.75 ] 0.90 [ 0.83, 0.94 ]
Zein 2004b 16 6 10 38 0.62 [ 0.41, 0.80 ] 0.86 [ 0.73, 0.95 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 5. Adults - platelet/spleen ratio - any varices.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 5 Adults - platelet/spleen ratio - any varices
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abu 2011 131 6 0 38 1.00 [ 0.97, 1.00 ] 0.86 [ 0.73, 0.95 ]
Agha 2009 154 5 0 152 1.00 [ 0.98, 1.00 ] 0.97 [ 0.93, 0.99 ]
Agha 2011 31 1 0 11 1.00 [ 0.89, 1.00 ] 0.92 [ 0.62, 1.00 ]
Amin 2012 61 5 7 22 0.90 [ 0.80, 0.96 ] 0.81 [ 0.62, 0.94 ]
Baig 2008 85 5 21 39 0.80 [ 0.71, 0.87 ] 0.89 [ 0.75, 0.96 ]
Camma 2009 52 16 11 25 0.83 [ 0.71, 0.91 ] 0.61 [ 0.45, 0.76 ]
Cherian 2011 118 10 60 41 0.66 [ 0.59, 0.73 ] 0.80 [ 0.67, 0.90 ]
Chiodi 2014 57 13 22 33 0.72 [ 0.61, 0.82 ] 0.72 [ 0.57, 0.84 ]
Colecchia 2012 43 6 10 41 0.81 [ 0.68, 0.91 ] 0.87 [ 0.74, 0.95 ]
De Mattos 2010 93 24 27 20 0.78 [ 0.69, 0.85 ] 0.45 [ 0.30, 0.61 ]
El Makarem 2011 131 6 0 38 1.00 [ 0.97, 1.00 ] 0.86 [ 0.73, 0.95 ]
El Ray 2015 57 1 3 19 0.95 [ 0.86, 0.99 ] 0.95 [ 0.75, 1.00 ]
Esmat 2012 79 3 3 15 0.96 [ 0.90, 0.99 ] 0.83 [ 0.59, 0.96 ]
Giannini 2003a 89 4 0 52 1.00 [ 0.96, 1.00 ] 0.93 [ 0.83, 0.98 ]
Giannini 2003b 71 29 0 21 1.00 [ 0.95, 1.00 ] 0.42 [ 0.28, 0.57 ]
Giannini 2005 27 11 0 30 1.00 [ 0.87, 1.00 ] 0.73 [ 0.57, 0.86 ]
Giannini 2006 108 33 10 67 0.92 [ 0.85, 0.96 ] 0.67 [ 0.57, 0.76 ]
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Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Gonzalez-Ojeda 2014 51 3 22 15 0.70 [ 0.58, 0.80 ] 0.83 [ 0.59, 0.96 ]
Karatzas 2016 13 9 10 5 0.57 [ 0.34, 0.77 ] 0.36 [ 0.13, 0.65 ]
Legasto 2006 42 4 27 77 0.61 [ 0.48, 0.72 ] 0.95 [ 0.88, 0.99 ]
Lei 2007 122 8 14 182 0.90 [ 0.83, 0.94 ] 0.96 [ 0.92, 0.98 ]
Mahassadi 2012a 70 6 15 20 0.82 [ 0.73, 0.90 ] 0.77 [ 0.56, 0.91 ]
Mahassadi 2012b 40 4 32 15 0.56 [ 0.43, 0.67 ] 0.79 [ 0.54, 0.94 ]
Mosqueira 2011 14 3 21 9 0.40 [ 0.24, 0.58 ] 0.75 [ 0.43, 0.95 ]
Parrino 2008 60 3 57 38 0.51 [ 0.42, 0.61 ] 0.93 [ 0.80, 0.98 ]
Schwarzenberger 2010 61 21 15 40 0.80 [ 0.70, 0.89 ] 0.66 [ 0.52, 0.77 ]
Sen 2008a 21 24 5 43 0.81 [ 0.61, 0.93 ] 0.64 [ 0.52, 0.76 ]
Sen 2008b 28 18 7 24 0.80 [ 0.63, 0.92 ] 0.57 [ 0.41, 0.72 ]
Sharma 2013 94 15 30 50 0.76 [ 0.67, 0.83 ] 0.77 [ 0.65, 0.86 ]
Sharma 2014 74 1 1 24 0.99 [ 0.93, 1.00 ] 0.96 [ 0.80, 1.00 ]
Sheta 2016 44 3 13 40 0.77 [ 0.64, 0.87 ] 0.93 [ 0.81, 0.99 ]
Stefanescu 2011 90 6 26 15 0.78 [ 0.69, 0.85 ] 0.71 [ 0.48, 0.89 ]
Takuma 2013 105 81 27 127 0.80 [ 0.72, 0.86 ] 0.61 [ 0.54, 0.68 ]
Wadhva 2012 54 12 14 31 0.79 [ 0.68, 0.88 ] 0.72 [ 0.56, 0.85 ]
Wang HM 2012 29 3 1 13 0.97 [ 0.83, 1.00 ] 0.81 [ 0.54, 0.96 ]
Xu 2016a 71 18 24 123 0.75 [ 0.65, 0.83 ] 0.87 [ 0.81, 0.92 ]
Zafar 2014 124 4 7 80 0.95 [ 0.89, 0.98 ] 0.95 [ 0.88, 0.99 ]
Zimbwa 2004 30 0 0 10 1.00 [ 0.88, 1.00 ] 1.00 [ 0.69, 1.00 ]
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Test 6. Adults - platelet/spleen ratio - any varices - cut-off 909.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 6 Adults - platelet/spleen ratio - any varices - cut-off 909
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Agha 2009 154 5 0 152 1.00 [ 0.98, 1.00 ] 0.97 [ 0.93, 0.99 ]
Amin 2012 61 5 7 22 0.90 [ 0.80, 0.96 ] 0.81 [ 0.62, 0.94 ]
Baig 2008 85 5 21 39 0.80 [ 0.71, 0.87 ] 0.89 [ 0.75, 0.96 ]
Colecchia 2012 43 6 10 41 0.81 [ 0.68, 0.91 ] 0.87 [ 0.74, 0.95 ]
De Mattos 2010 93 24 27 20 0.78 [ 0.69, 0.85 ] 0.45 [ 0.30, 0.61 ]
Giannini 2003a 89 4 0 52 1.00 [ 0.96, 1.00 ] 0.93 [ 0.83, 0.98 ]
Giannini 2003b 71 29 0 21 1.00 [ 0.95, 1.00 ] 0.42 [ 0.28, 0.57 ]
Giannini 2005 27 11 0 30 1.00 [ 0.87, 1.00 ] 0.73 [ 0.57, 0.86 ]
Giannini 2006 108 33 10 67 0.92 [ 0.85, 0.96 ] 0.67 [ 0.57, 0.76 ]
Legasto 2006 42 4 27 77 0.61 [ 0.48, 0.72 ] 0.95 [ 0.88, 0.99 ]
Mosqueira 2011 14 3 21 9 0.40 [ 0.24, 0.58 ] 0.75 [ 0.43, 0.95 ]
Schwarzenberger 2010 61 21 15 40 0.80 [ 0.70, 0.89 ] 0.66 [ 0.52, 0.77 ]
Sharma 2014 74 1 1 24 0.99 [ 0.93, 1.00 ] 0.96 [ 0.80, 1.00 ]
Takuma 2013 105 81 27 127 0.80 [ 0.72, 0.86 ] 0.61 [ 0.54, 0.68 ]
Xu 2016a 71 18 24 123 0.75 [ 0.65, 0.83 ] 0.87 [ 0.81, 0.92 ]
Zafar 2014 124 4 7 80 0.95 [ 0.89, 0.98 ] 0.95 [ 0.88, 0.99 ]
Zimbwa 2004 30 0 0 10 1.00 [ 0.88, 1.00 ] 1.00 [ 0.69, 1.00 ]
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Test 7. Adults - spleen diameter - any varices.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 7 Adults - spleen diameter - any varices
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Baig 2008 79 14 27 30 0.75 [ 0.65, 0.82 ] 0.68 [ 0.52, 0.81 ]
Colecchia 2012 21 6 32 41 0.40 [ 0.26, 0.54 ] 0.87 [ 0.74, 0.95 ]
Ditchfield 1992 30 12 33 11 0.48 [ 0.35, 0.61 ] 0.48 [ 0.27, 0.69 ]
Esmat 2012 74 3 8 15 0.90 [ 0.82, 0.96 ] 0.83 [ 0.59, 0.96 ]
Grgurevic 2014 39 5 48 25 0.45 [ 0.34, 0.56 ] 0.83 [ 0.65, 0.94 ]
Jeon 2006 21 10 4 17 0.84 [ 0.64, 0.95 ] 0.63 [ 0.42, 0.81 ]
Mahassadi 2012a 44 8 41 18 0.52 [ 0.41, 0.63 ] 0.69 [ 0.48, 0.86 ]
Parrino 2008 47 1 70 40 0.40 [ 0.31, 0.50 ] 0.98 [ 0.87, 1.00 ]
Primignani 2002 32 95 10 113 0.76 [ 0.61, 0.88 ] 0.54 [ 0.47, 0.61 ]
Sen 2008a 21 24 5 43 0.81 [ 0.61, 0.93 ] 0.64 [ 0.52, 0.76 ]
Sen 2008b 25 19 10 23 0.71 [ 0.54, 0.85 ] 0.55 [ 0.39, 0.70 ]
Tarantino 2009 34 16 36 67 0.49 [ 0.36, 0.61 ] 0.81 [ 0.71, 0.89 ]
Wang CC 2015 25 7 1 9 0.96 [ 0.80, 1.00 ] 0.56 [ 0.30, 0.80 ]
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Test 8. Adults - spleen diameter - any varices - cut-off around 110 mm.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 8 Adults - spleen diameter - any varices - cut-off around 110 mm
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Baig 2008 79 14 27 30 0.75 [ 0.65, 0.82 ] 0.68 [ 0.52, 0.81 ]
Colecchia 2012 49 27 4 20 0.92 [ 0.82, 0.98 ] 0.43 [ 0.28, 0.58 ]
Jeon 2006 21 10 4 17 0.84 [ 0.64, 0.95 ] 0.63 [ 0.42, 0.81 ]
Primignani 2002 32 95 10 113 0.76 [ 0.61, 0.88 ] 0.54 [ 0.47, 0.61 ]
Wang CC 2015 25 7 1 9 0.96 [ 0.80, 1.00 ] 0.56 [ 0.30, 0.80 ]
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Test 9. Adults - spleen diameter - any varices - cut-off around 150 mm.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 9 Adults - spleen diameter - any varices - cut-off around 150 mm
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Colecchia 2012 21 6 32 41 0.40 [ 0.26, 0.54 ] 0.87 [ 0.74, 0.95 ]
Mahassadi 2012a 44 8 41 18 0.52 [ 0.41, 0.63 ] 0.69 [ 0.48, 0.86 ]
Parrino 2008 34 16 36 67 0.49 [ 0.36, 0.61 ] 0.81 [ 0.71, 0.89 ]
Sen 2008a 21 24 5 43 0.81 [ 0.61, 0.93 ] 0.64 [ 0.52, 0.76 ]
Tarantino 2009 47 1 70 23 0.40 [ 0.31, 0.50 ] 0.96 [ 0.79, 1.00 ]
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Test 10. Adults - platelet count - high-risk varices.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 10 Adults - platelet count - high-risk varices
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abd-Elsalam 2016b 41 36 10 23 0.80 [ 0.67, 0.90 ] 0.39 [ 0.27, 0.53 ]
Burton 2007a 1 8 2 25 0.33 [ 0.01, 0.91 ] 0.76 [ 0.58, 0.89 ]
Burton 2007b 16 27 11 84 0.59 [ 0.39, 0.78 ] 0.76 [ 0.67, 0.83 ]
Burton 2007c 3 9 0 62 1.00 [ 0.29, 1.00 ] 0.87 [ 0.77, 0.94 ]
Castera 2009 10 14 3 43 0.77 [ 0.46, 0.95 ] 0.75 [ 0.62, 0.86 ]
Cherian 2011 48 53 33 95 0.59 [ 0.48, 0.70 ] 0.64 [ 0.56, 0.72 ]
Chiodi 2014 35 26 18 46 0.66 [ 0.52, 0.78 ] 0.64 [ 0.52, 0.75 ]
Ding 2016 17 65 9 180 0.65 [ 0.44, 0.83 ] 0.73 [ 0.67, 0.79 ]
Esmat 2012 42 18 18 22 0.70 [ 0.57, 0.81 ] 0.55 [ 0.38, 0.71 ]
Madhotra 2002 17 43 7 117 0.71 [ 0.49, 0.87 ] 0.73 [ 0.66, 0.80 ]
Mahassadi 2012a 61 13 17 20 0.78 [ 0.67, 0.87 ] 0.61 [ 0.42, 0.77 ]
Mahassadi 2012b 33 6 27 25 0.55 [ 0.42, 0.68 ] 0.81 [ 0.63, 0.93 ]
Pilette 1999 41 27 10 38 0.80 [ 0.67, 0.90 ] 0.58 [ 0.46, 0.71 ]
Sanyal 2006 32 152 29 803 0.52 [ 0.39, 0.65 ] 0.84 [ 0.82, 0.86 ]
Sarangapani 2010 37 14 14 41 0.73 [ 0.58, 0.84 ] 0.75 [ 0.61, 0.85 ]
Sebastiani 2010 52 91 45 322 0.54 [ 0.43, 0.64 ] 0.78 [ 0.74, 0.82 ]
Tafarel 2011 69 82 36 113 0.66 [ 0.56, 0.75 ] 0.58 [ 0.51, 0.65 ]
Wang JH 2012 11 32 2 81 0.85 [ 0.55, 0.98 ] 0.72 [ 0.62, 0.80 ]
Zaman 2001 59 67 35 139 0.63 [ 0.52, 0.73 ] 0.67 [ 0.61, 0.74 ]
Zein 2004a 14 29 5 135 0.74 [ 0.49, 0.91 ] 0.82 [ 0.76, 0.88 ]
Zein 2004b 7 15 1 47 0.88 [ 0.47, 1.00 ] 0.76 [ 0.63, 0.86 ]
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Test 11. Adults - platelet count - high-risk varices - cut-off around 90,000.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 11 Adults - platelet count - high-risk varices - cut-off around 90,000
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abd-Elsalam 2016b 24 22 27 37 0.47 [ 0.33, 0.62 ] 0.63 [ 0.49, 0.75 ]
Burton 2007a 1 8 2 25 0.33 [ 0.01, 0.91 ] 0.76 [ 0.58, 0.89 ]
Burton 2007b 16 27 11 84 0.59 [ 0.39, 0.78 ] 0.76 [ 0.67, 0.83 ]
Burton 2007c 3 9 0 62 1.00 [ 0.29, 1.00 ] 0.87 [ 0.77, 0.94 ]
Cherian 2011 48 53 33 95 0.59 [ 0.48, 0.70 ] 0.64 [ 0.56, 0.72 ]
Ding 2016 17 65 9 180 0.65 [ 0.44, 0.83 ] 0.73 [ 0.67, 0.79 ]
Esmat 2012 42 18 18 22 0.70 [ 0.57, 0.81 ] 0.55 [ 0.38, 0.71 ]
Sanyal 2006 32 152 29 803 0.52 [ 0.39, 0.65 ] 0.84 [ 0.82, 0.86 ]
Sebastiani 2010 52 91 45 322 0.54 [ 0.43, 0.64 ] 0.78 [ 0.74, 0.82 ]
Tafarel 2011 69 82 36 113 0.66 [ 0.56, 0.75 ] 0.58 [ 0.51, 0.65 ]
Zaman 2001 59 67 35 139 0.63 [ 0.52, 0.73 ] 0.67 [ 0.61, 0.74 ]
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Test 12. Adults - platelet count - high-risk varices - cut-off around 150,000.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 12 Adults - platelet count - high-risk varices - cut-off around 150,000
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abd-Elsalam 2016b 41 36 10 23 0.80 [ 0.67, 0.90 ] 0.39 [ 0.27, 0.53 ]
Castera 2009 10 14 3 43 0.77 [ 0.46, 0.95 ] 0.75 [ 0.62, 0.86 ]
Pilette 1999 41 27 10 38 0.80 [ 0.67, 0.90 ] 0.58 [ 0.46, 0.71 ]
Sanyal 2006 55 401 6 554 0.90 [ 0.80, 0.96 ] 0.58 [ 0.55, 0.61 ]
Sarangapani 2010 37 14 14 41 0.73 [ 0.58, 0.84 ] 0.75 [ 0.61, 0.85 ]
Zein 2004a 14 29 5 135 0.74 [ 0.49, 0.91 ] 0.82 [ 0.76, 0.88 ]
Zein 2004b 7 15 1 47 0.88 [ 0.47, 1.00 ] 0.76 [ 0.63, 0.86 ]
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Test 13. Adults - platelet/spleen ratio - high-risk varices.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 13 Adults - platelet/spleen ratio - high-risk varices
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Barikbin 2010 30 6 1 13 0.97 [ 0.83, 1.00 ] 0.68 [ 0.43, 0.87 ]
Chiodi 2014 33 27 20 45 0.62 [ 0.48, 0.75 ] 0.63 [ 0.50, 0.74 ]
Esmat 2012 56 24 4 16 0.93 [ 0.84, 0.98 ] 0.40 [ 0.25, 0.57 ]
Grgurevic 2014 18 70 0 29 1.00 [ 0.81, 1.00 ] 0.29 [ 0.21, 0.39 ]
Mahassadi 2012a 66 12 12 21 0.85 [ 0.75, 0.92 ] 0.64 [ 0.45, 0.80 ]
Mahassadi 2012b 38 8 22 23 0.63 [ 0.50, 0.75 ] 0.74 [ 0.55, 0.88 ]
Mosqueira 2011 11 6 11 19 0.50 [ 0.28, 0.72 ] 0.76 [ 0.55, 0.91 ]
Sarangapani 2010 45 9 6 46 0.88 [ 0.76, 0.96 ] 0.84 [ 0.71, 0.92 ]
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Schwarzenberger 2010 23 59 2 53 0.92 [ 0.74, 0.99 ] 0.47 [ 0.38, 0.57 ]
Wang HM 2012 18 14 1 13 0.95 [ 0.74, 1.00 ] 0.48 [ 0.29, 0.68 ]
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Test 14. Adults - platelet/spleen ratio - high-risk varices - cut-off around 909.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 14 Adults - platelet/spleen ratio - high-risk varices - cut-off around 909
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Barikbin 2010 30 6 1 13 0.97 [ 0.83, 1.00 ] 0.68 [ 0.43, 0.87 ]
Esmat 2012 56 24 4 16 0.93 [ 0.84, 0.98 ] 0.40 [ 0.25, 0.57 ]
Mahassadi 2012a 66 12 12 21 0.85 [ 0.75, 0.92 ] 0.64 [ 0.45, 0.80 ]
Mahassadi 2012b 38 8 22 23 0.63 [ 0.50, 0.75 ] 0.74 [ 0.55, 0.88 ]
Mosqueira 2011 11 6 11 19 0.50 [ 0.28, 0.72 ] 0.76 [ 0.55, 0.91 ]
Sarangapani 2010 45 9 6 46 0.88 [ 0.76, 0.96 ] 0.84 [ 0.71, 0.92 ]
Schwarzenberger 2010 23 59 2 53 0.92 [ 0.74, 0.99 ] 0.47 [ 0.38, 0.57 ]
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Test 15. Adults - spleen diameter - high-risk varices.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 15 Adults - spleen diameter - high-risk varices
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Cherian 2011 54 67 27 81 0.67 [ 0.55, 0.77 ] 0.55 [ 0.46, 0.63 ]
Esmat 2012 43 13 17 27 0.72 [ 0.59, 0.83 ] 0.68 [ 0.51, 0.81 ]
Madhotra 2002 18 68 6 92 0.75 [ 0.53, 0.90 ] 0.58 [ 0.49, 0.65 ]
Mahassadi 2012a 49 8 29 25 0.63 [ 0.51, 0.74 ] 0.76 [ 0.58, 0.89 ]
Sarangapani 2010 45 9 6 46 0.88 [ 0.76, 0.96 ] 0.84 [ 0.71, 0.92 ]
Tarantino 2009 18 32 18 85 0.50 [ 0.33, 0.67 ] 0.73 [ 0.64, 0.80 ]
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Test 16. Paediatrics - platelet count - any varices.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 16 Paediatrics - platelet count - any varices
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Adami 2013 48 6 23 26 0.68 [ 0.55, 0.78 ] 0.81 [ 0.64, 0.93 ]
Alcantara 2012 13 2 4 16 0.76 [ 0.50, 0.93 ] 0.89 [ 0.65, 0.99 ]
Colecchia 2011 8 1 7 15 0.53 [ 0.27, 0.79 ] 0.94 [ 0.70, 1.00 ]
Gana 2011 60 10 14 24 0.81 [ 0.70, 0.89 ] 0.71 [ 0.53, 0.85 ]
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Test 17. Paediatrics - platelet/spleen ratio z-score - any varices.
Review: Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein
thrombosis
Test: 17 Paediatrics - platelet/spleen ratio z-score - any varices
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Adami 2013 45 5 20 19 0.69 [ 0.57, 0.80 ] 0.79 [ 0.58, 0.93 ]
Gana 2011 61 16 13 18 0.82 [ 0.72, 0.90 ] 0.53 [ 0.35, 0.70 ]
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A D D I T I O N A L T A B L E S
Table 1. Any varices - comparisons between tests
Any varices - indirect comparisons Any varices - indir
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* Pair-wise comparisons between index tests performed by adding the index test as covariate to the bivariate model. P values were
obtained by comparing the -2 log likelihood of the model with the covariate with the -2 log likelihood of the model without the
covariate.
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Table 2. Summary of diagnostic accuracy results (Continued)
A P P E N D I C E S
Appendix 1. Search strategies
Database Time span Search strategy
Cochrane Hepato-Biliary Group Con-
trolled Trials Register
June 2016 ((((platelet* or thrombocyt*) near (count or distribution or vol-
ume)) or PLT or PDW orMPV)OR (((splenic* or spleen*) near3
(enlarg* or hypertroph or length or palpable or size or diamet*
or index or examin*)) or splenomegal*)) AND (*esophag* near3
(varic* or varix*))
Cochrane Hepato-Biliary Diagnostic Test
of Accuracy Studies Register
June 2016 ((((platelet* or thrombocyt*) near (count or distribution or vol-
ume)) or PLT or PDW orMPV)OR (((splenic* or spleen*) near3
(enlarg* or hypertroph or length or palpable or size or diamet*
or index or examin*)) or splenomegal*)) AND (*esophag* near3
(varic* or varix*))
The Cochrane Library 2016, Issue 6 #1 MeSH descriptor: [Platelet Count] explode all trees
#2 ((platelet* or thrombocyt*) near (count or distribution or vol-
ume)) or PLT or PDW or MPV
#3 #1 or #2
#4 MeSH descriptor: [Splenomegaly] explode all trees
#5 ((splenic* or spleen*) near/3 (enlarg* or hypertroph or length or
palpable or size or diamet* or index or examin*)) or splenomegal*
#6 #4 or #5
#7 MeSH descriptor: [Esophageal and Gastric Varices] explode
all trees
#8 *esophag* near/3 (varic* or varix*)
#9 #7 or #8
#10 (#3 or #6) and #9
MEDLINE (OvidSP) 1946 to June 2016. 1. exp Platelet Count/
2. (((platelet* or thrombocyt*) adj (count or distribution or vol-
ume)) or PLT or PDW or MPV).mp. [mp=title, abstract, origi-
nal title, name of substance word, subject heading word, keyword
heading word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier]
3. 1 or 2
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(Continued)
4. exp Splenomegaly/
5. (((splenic* or spleen*) adj3 (enlarg* or hypertroph or length or
palpable or size or diamet* or index or examin*)) or splenomegal*)
.mp. [mp=title, abstract, original title, name of substance word,
subject heading word, keyword heading word, protocol supple-
mentary concept word, rare disease supplementary concept word,
unique identifier]
6. 4 or 5
7. (Esophageal and Gastric Varices).mp. [mp=title, abstract, origi-
nal title, name of substance word, subject heading word, keyword
heading word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier]
8. ((esophag* or oesophag*) adj3 (varic* or varix*)).mp. [mp=title,
abstract, original title, name of substance word, subject heading
word, keyword heading word, protocol supplementary concept
word, rare disease supplementary conceptword, unique identifier]
9. 7 or 8
10. (3 or 6) and 9
Embase (OvidSP) 1974 to June 2016 1. exp thrombocyte count/
2. (((platelet* or thrombocyt*) adj (count or distribution or vol-
ume)) or PLT or PDW orMPV).mp. [mp=title, abstract, heading
word, drug trade name, original title, device manufacturer, drug
manufacturer, device trade name, keyword]
3. 1 or 2
4. exp splenomegaly/
5. (((splenic* or spleen*) adj3 (enlarg* or hypertroph or length or
palpable or size or diamet* or index or examin*)) or splenomegal*)
.mp. [mp=title, abstract, heading word, drug trade name, original
title, device manufacturer, drug manufacturer, device trade name,
keyword]
6. 4 or 5
7. exp esophagus varices/
8. ((esophag* or oesophag*) adj3 (varic* or varix*)).mp. [mp=title,
abstract, heading word, drug trade name, original title, device
manufacturer, drug manufacturer, device trade name, keyword]
9. 7 or 8
10. (3 or 6) and 9
Science Citation Index - Expanded 1900 to June 2016 #5 #4 AND #3
#4 TS=(*esophag* NEAR/3 (varic* or varix*))
#3 #2 OR #1
#2 TS=(((splenic* or spleen*) NEAR/3 (enlarg* or hypertroph or
length or palpable or size or diamet* or index or examin*)) or
splenomegal*)
#1 TS=(((platelet* or thrombocyt*) NEAR (count or distribution
or volume)) or PLT or PDW or MPV)
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Appendix 2. QUADAS-2
Domain 1. Participant selection 2. Index test 3. Reference standard 4. Flow and timing
Signalling questions
and criteria
Q.1: “Was a consecutive
or random sample of par-
ticipants enrolled?”
Yes - If the study reports
on a consecutive or a ran-
dom selection of partici-
pants
No - if the study reports
on another form of selec-
tion of participants
Unclear - if the study
does not report on how
the participants were en-
rolled
Q.2: “Was a case-control
design avoided?”
Yes - if the case-control
design was avoided.
No - if the study was a
case-control.
Unclear - if the study de-
sign was not clear.
Q.3: “Did the study avoid
inappropriate exclusions?”
Yes - if the study defini-
tions of exclusion criteria
are appropriate (i.e. pre-
vious bleeding or treat-
ment for oesophageal
varices) and all exclu-
sions are reported
No - if exclusion criteria
are inappropriate and ex-
clusions are not reported
Unclear - if the study
does not report causes of
exclusions.
Q.1: “Were the index test
results interpreted without
knowledge of the results of
the reference standard?”
Yes - if the study reports
that results of the in-
dex test were interpreted
without the knowledge
of results of the reference
standard
No - if the study reports
that results of the in-
dex test were interpreted
with results of the refer-
ence standard
Unclear - if the study
does not report informa-
tion about blinding of re-
sults of the index test and
reference standard
Q.2: “If a threshold was
used, was it prespecified?
”
Yes - if the threshold
used was reported in the
methods section
No - if the study reports
that the threshold was
chosen during the data
analysis stage (e.g. maxi-
mum of Youden index)
Unclear - if the study
does not report informa-
tion about threshold se-
lection
Q.1: “Is the reference stan-
dard likely to correctly
classify the target condi-
tion?”




grading scores or sys-
tems detailed in “Refer-
ence Standard” section)
No - if there is some
doubt whether the ref-
erence standard classifies
oesophageal varices
Unclear - if the study
does not report on the
reference standard used
Q.2: “Were the refer-
ence standard results in-
terpreted without knowl-
edge of results of the index
test?”
Yes - if the study reports
that results of the refer-
ence standard were inter-
preted without knowl-
edge of results of the in-
dex test
No - if the study reports
that results of the refer-
ence standard were inter-
preted with results of the
test index
Unclear - if the study
does not report informa-
tion about blinding of
results of the reference
standard and the index
test
Q.1: “Was there an ap-
propriate interval between
the index test and the ref-
erence standard?”
Yes - if the interval be-
tween the index test and
the reference standard
was less than 3 months
No - if the interval was
longer than 3 months.
Unclear - if the study
does not report the in-
terval between the in-
dex test and the reference
standard
Q.2: “Did all participants
receive the same reference
standard?”
Yes - if the study has
only one reference stan-
dard for all participants
(OGD with appropri-
ate classification of oe-
sophageal varices)
No - if the study has
more than one reference
standard.
Unclear- if the study is
not clear about the refer-
ence standard used
Q.3 “Were all partic-
ipants included in the
analysis?”
Answer:
Yes - if all enrolled partic-
ipants were included in
the analysis (even in the
case of uninterpretable
index test result)
No - if any participant
was excluded from the
analysis for any reason
Unclear - if it is not clear
about exclusions of par-
ticipants from the analy-
sis
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(Continued)
Risk of bias Could the selection of par-
ticipants have introduced
bias?
Low risk: “Yes” for all sig-
nalling questions.
High risk: “No” or “Un-
clear” for at least one sig-
nalling question
Could the conduct or in-
terpretation of the index
test have introduced bias?
Low risk: “Yes” for the
signalling question.
High risk: “No” or “Un-
clear” for the signalling
question.
Could the reference stan-
dard, its conduct, or its
interpretation have intro-
duced bias?
Low risk: “Yes” for all sig-
nalling questions.
High risk: “No” or “Un-
clear” for at least one sig-
nalling question
Could
the participant flow have
introduced bias?
Low risk: “Yes” for all sig-
nalling questions.
High risk: “No” or “Un-




Are there concerns that the
included participants and
setting do not match the
review question?
Low concern: Partici-
pants included in the
review represent partici-
pants for whom the test
is used in clinical practice
High concern: Partici-
pants included in the re-
view differ from partici-
pants for whom the test
is used in clinical practice
Are there concerns that the
index test, its conduct, or
interpretation differ from
the review question?
High concern: The in-
dex test, its conduct, or
interpretation of the in-
dex test differs from the
way it is used in clinical
practice
Low concern: The index
test, its conduct, or in-
terpretation of the index
test does not differ from
the way it is used in clin-
ical practice
Are there concerns that the
target condition as defined
by the reference standard
does not match the ques-
tion?
-
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At the review stage, we decided to analyse paediatric and adult patients separately, as we found only studies enrolling only adult people
or only paediatric patients. Furthermore, transitivity of results to children is unknown.
Analyses of sources of heterogeneity were added as secondary objectives, in accordance with recommendations provided in theCochrane
Handbook for Diagnostic Test of Accuracy Reviews.
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